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Introduction and aim of the thesis. 
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Bone augmentation for dental implants 
Dental implants have revolutionised dentistry in many aspects since their 
introduction in general practice in the 1970’s. They have widened treatment 
options for the dental practitioners and their patients. The anchorage of a 
dental implant directly to bone provides extra retention for patients who have 
lack of retention for removable prostheses. They are spared much pain and 
discomfort as well as social difficulties by the placement of implants (Davis 
1998, Kent & Johns 1994). Even partially edentulous patients benefit from 
single and multiple teeth replacement by implant-supported crown and 
bridge work. This has not however, been effortlessly. After the initial 
problems due to implant design, sterility and materials were solved the 
problem of implant placement remained. The premature loss of teeth leads to 
gradual resorption of the alveolar ridge. In some cases this can lead to such 
severe bone loss that placement of a dental implant is impossible (Taylor & 
Agar 2002, Van den Berg et al. 1998). Particularly the maxilla is reputed to 
have poor bone quality and experience has shown that bone can resorb very 
quickly, especially in the posterior sites. In the early days of dental 
implantology implants were placed where bone was still available and not 
where it was functionally or even aesthetically desired. Augmentation of 
bone tissue at the desired place resolved this problem.  
Since the 1980s bone regeneration (or augmentation) procedures have 
become a regular tool for improving the environment in which implants are 
placed. In dentistry, bone grafting is still the most predictable method of 
enlarging or correcting sites where bone quantity is insufficient (Block & 
Kent 1997, Lundgren et al. 1996, Blomqvist et al. 1998). Trabecular bone is 
harvested, usually from the crista iliaca, cut into small pieces and applied to 
the jaw defect. Such a graft works predictably, and eliminates risks of cross-
reactions experienced when transferring tissues from other humans or even 
from other species.  However, in certain cases a graft of trabecular bone 
chips is contra-indicated by the lack of structural support at the site of 
augmentation (Windmark et al. 1997). Loss of teeth in the anterior maxilla is 
an example. Here block-grafting is the technique of choice.  
Block-grafting is a way of grafting large defects that need some degree of 
structural support. Normally when given a choice, blocks are avoided in 
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preference of smaller particles of bone (trabecular bone chips), which are 
more likely to regenerate (Merkx 2000), since blood supply is more readily 
re-established. However, particles provide no structure to hold the graft in 
place and avoid micro movement. Monocortical blocks obtained from the 
symphysis can fill the defect and correct the three dimensional shape of the 
bone defect. They can be anchored in the desired position with screws, 
making them mechanically stable. The histological events taking place in the 
block are however poorly understood and this is researched in chapter 2. We 
set out to determine histologically whether the bone block survived the 
transient ischaemia and if not, to find out how and if the grafted bone would 
be remodelled into vital bone. Vitality was determined by assessing 
histologically the presence of live osteocytes in the graft at different times. 
We wanted to understand the biological process taking place in these grafts 
and to give further insight to clinicians concerning time of implant 
placement for these grafts. 
Even in defects with good initial support for the graft, trabecular 
autologous bone has an important disadvantage: it needs to be harvested 
from elsewhere in the skeleton. This means another operation, including the 
risks of hospitalisation, general anaesthesia and donor site morbidity 
(Wheeler 1997, Kalk et al. 1996, Raghoebar et al. 2001). Therefore 
alternative materials have been researched. Most bone substitute materials 
can be categorised as osteoconductive, a few are even osteoinductive. An 
osteoconductive material is a biocompatible material that allows 
osteoprogenitor cell in-growth (derived from adjacent bone), which is then 
capable of differentiating into bone producing cells and lay down osteoid. 
Osteoinduction on the other hand, is the ability of a substance to induce a 
change in undifferentiated cells, into osteoprogenitor cells capable of 
differentiating further into bone forming cells. Bone morphogenetic proteins 
are a notable example (Groeneveld et al. 1999a).  
Osteoconductive materials can be derived from other humans (allografts, 
Groeneveld et al.1999b, van de Bergh et al. 2000), from other species 
(xenografts, Tadjoedin et al. 2003, Valentini et al. 2000, Valentini & 
Abensur 2003, Camelo et al. 1998) or be synthetic (alloplasts, Tadjoedin et 
al. 2000). An ideal bone substitute material should be well accepted in its 
environment, should have no risk of contamination from impurities or 
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diseases and should give rise to new bone leaving no traces of itself. We 
therefore decided to look into a purely synthetic bone substitute, the β-
tricalcium phosphate (TCP). 
Calcium phosphates have been used in the past for bone augmentation 
with mixed success (Cameron 1977, Driessens et al. 1992, LeGeros 2002). 
Initially successful were the dense sintered hydroxyapatites, which do not 
resorb but allow bone to grow around it, thereby embedding it in live bone 
but never replacing it. Their continuous presence in the body is nowadays 
considered unwanted. Porous calcium phosphates became popular because 
they enabled cell in-growth in the interconnecting pores, which improved 
their mechanical properties (Bucholz 2002). Cerasorb® is a β-tricalcium 
phosphate that has been used for some time in dental surgery. It is made up 
of primary micro-particles that are sintered into a porous granule of varying 
diameter, but constant micro-porosity (Tadic & Epple 2004). According to 
the manufacturer, it should resorb completely within 12-24 months. Made of 
calcium phosphate, the most common mineral in the body, there are no 
adverse cellular reactions expected, and in time the material should either be 
replaced by bone or integrated into the body, depending on the degradation 
properties. Animal studies showed promising results, even at the histological 
level (Merten et al. 2002, Wiltfang et al. 2002). However, a thorough case-
controlled study in humans was lacking. In particular, there was and still is a 
need for quantitative histological data to allow comparison with autologous 
bone grafts and provide a base for clinical decision-making. In chapter 3 we 
tried this material in two patient situations, using qualitative histology. This 
case study was used to give insight in the potential of the material prior to 
setting up a controlled clinical trial described in chapter 4. Here we 
compared Cerasorb® with autologous bone grafted from the symphysis, 
using quantitative histomorphometry. Chapter 5 is a more in-depth immuno 
and enzyme histochemical study of the soft connective tissue found 
infiltrating the Cerasorb® material. The study was carried out to determine 
whether this connective tissue had osteogenic potential or would lead to soft 
connective tissue encapsulation without subsequent bone formation. 
Furthermore, we studied the mechanism of degradation of the TCP. The 
sixth chapter reports on three cases with prolonged healing with Cerasorb®.  
The study was used to determine if with longer healing times the bone 
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density would still increase, in comparison to the 6 months data. 
Furthermore we wanted to establish the effect of time on the maturity of the 
bone and to determine if there were clinical advantages in delaying the 
implant placement. 
 
Sinus lifting for histological study 
The model used for testing the TCP material for bone augmentation in 
humans was the sinus floor augmentation.  This technique makes use of the 
maxillary sinus space to increase bone height in the posterior maxilla when 
there was inadequate alveolar ridge height remaining for implant placement 
(fig 1a and 1b). First introduced to dentistry by Boyne and James in 1980 
and later modified by Tatum in 1986, sinus floor augmentation has become 
part of the routine pre-prosthetic surgery.   
The procedure is based on opening the maxillary antrum from its lateral 
aspect, and placing a graft material over the original sinus floor, thus making 
the sinus cavity smaller and at the same time increasing the height of the 
ridge separating the oral cavity and the maxillary antrum cavity. In this way 
the floor of the sinus is at a higher level, or augmented (fig. 2).  
The usefulness of this model for material comparisons can be attributed 
to two main factors. Firstly, since the augmentation is carried out during one 
operation and implants are placed at a later stage, biopsies can be taken at 
the second operation to be used for histological analysis. The second 
important reason is that patients requiring augmentation on both sides of the 
maxilla provide us with an almost unique intra-patient comparison for two 
different materials (autologous trabecular bone in one sinus versus a test 
material in the other). Despite this, there are very few human studies that use 
histology, and quantified studies of bone substitute materials are even 
scarcer (Szabó et al. 2001, Tadjoedin et al. 2000, Tadjoedin et al. 2003). 
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prosthetics (fig.2.d). (Reprint of pictures from book “ The Sinus Graft” by Ole T. Jensen 1999 
with permission from publisher Quintessence books, Co, Inc.) 
 
The biopsies for these studies are obtained by using a hollow trephine 
burr to prepare the implant site. The core of tissue removed by the trephine is 
preserved as biopsy to be used for histological examination. This makes this 
model very acceptable from an ethical point of view, since it does not harm 
the patient and does not require any extra invasive treatment in order to 
retrieve the biopsies. Histology performed on these biopsies can be used to 
evaluate the behaviour of a bone substitute and the composition of the new 
bone at the site of implant placement. Light microscopy in combination with 
appropriate enzyme-histochemistry and immunostaining has the potential to 
give considerable extra information. Labeling of the growing bone over time 
using tetracycline gives us even insight into the bone dynamics. 
Histomorphometry (the quantitative measurement of histological features) 
provides quantitative data for comparison between different treatments.  A 
wealth of information is thus obtained from these biopsies, of exactly the site 
where implants were placed. Alternative, non-invasive techniques such as 
radiography, computer tomography (CT), micro-CT and magnetic resonance 
imaging (MRI) all provide much less detail, and say nothing of the vitality 
and vascularisation of the augmented tissue. 
 
Aim of the thesis  
In sum, the present thesis aimed at answering the following questions: 
- Do monocortical bone blocks provide sufficient bone quantity and 
quality to augment bone defects in the anterior maxilla? 
- What happens to the osteocytes in the grafted bone blocks, do they 
survive grafting, or do they die?  
- By what mechanism does Cerasorb® bring about new bone formation 
and is it useful for sinus augmentations? 
- What are the guidelines for use of this TCP in clinics? 
- How is the material replaced and degraded. 
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Abstract 
Local bone defects in the anterior maxilla are commonly grafted 
with monocortical blocks of autologous bone in order to restore the
defect site prior to the placement of dental implants. Increasing
evidence suggests that osteocytes are involved in control of bone 
remodelling and thus may be important for optimalisation of bone
structure around implants and thus for implant osseointegration
However, it is not well known whether osteocytes will survive when
bone blocks are grafted into defects. 
We grafted 19 patients with monocortical bone blocks derived from 
the symphysis, to the defect site in the maxillary alveolar process. The bone 
grafts were left to heal for times varying from 2.5 to 7 months. During 
implant installation, bone biopsies were removed using a trephine burr, and 
processed for hard tissue histology. Bone histology and histomorphometry 
were then carried out in order to gain insight into the density, viability and 
remodelling of the graft. 
Clinically, all the bone grafts were successful with no implant 
failures and little resorption was seen. Histologically, bone volume 
expressed as percentage tissue volume at the implant site varied from 27% to 
57% with an overall average of 41 %. Bone fields with empty osteocyte 
lacunae were observed and measured. The amount of this so-called non-vital 
bone varied between 1 and 34% of the total tissue volume. The amount of 
non-vital bone decreased significantly with the time of healing.  
The data suggests that the majority of the osteocytes of the 
monocortical bone do not survive grafting. The results indicate that the non-
vital bone is progressively remodelled into new vital bone in 7 months after 
grafting.  
 
Introduction 
Bone defects in the human maxilla are a common finding. They are 
mostly derived from premature loss of a tooth due to periapical infection 
following decay or trauma. In order to restore this situation prior to 
implantation a bone augmenting procedure has to be carried out.  The use of 
autologous bone has been accepted for a considerable time to be the most 
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predictable method of grafting bone defects (Listrom & Symington 1988, 
Jensen & Sindet-Pedersen 1991, Block & Kent 1997).  The bone may be 
harvested from a variety of sites, intra-orally, from the retromolar, ramus or 
the symphysis (Misch 1997, Jensen & Sindet-Pedersen 1991, Hunt & 
Jovanovic 1999, Windmark et al 1997, Montazem et al. 2000) or 
alternatively from extra-oral sites such as iliac bone, calvarium or tibia 
(Block & Kent 1997).  The symphysis is a well-accepted donor site for 
grafting since it is easily accessible, contains adequate amounts of bone and 
can be obtained without aesthetic consequence (Devlin et al. 1994, Misch 
1997). Grafts from the symphysis show less resorption, when compared to 
those from the crista iliaca (Koole 1994, Lundgren et al. 1996). Goldberg & 
Stevenson (1987) described that a bone graft has two main functions: to be a 
source of osteogenic cells and a mechanical support. A bone block is 
preferred for this type of augmentation, since it provides both the source of 
cells and a rigid structure. Blocks are less likely to fail due to micro-
movement during the in-growth of new bone, which could be the case when 
bone chips are used. The bone that can be grafted from this area is easily 
shaped to fit the defect site and can be stabilised simply with screws. 
Although this treatment is well accepted in clinical practice, there are a 
number of unanswered questions about the biological process taking place in 
the bone graft.  We wanted to know whether bone tissue cells, particularly 
the osteocytes that are completely entombed by mineralised bone, survive 
transplantation or die due to the transient lack of vascularisation.  Vitality of 
osteocytes may be important for bone remodeling around implants, since 
these cells are currently believed to be involved in bone turnover by 
secreting signalling factors. These factors communicate with the bone 
surface, which control the activity of bone surface cells such as osteoblasts, 
osteoclasts and bone lining cells (e.g. Smith & Burger 2002, Zhao et al. 
2002). It was also of interest to know the timing of the remodelling process 
in order to understand the biological process so that the clinical protocol can 
be adjusted accordingly. 
Although studies have been conducted to assess the results of bone 
grafts from the human mandibular symphysis (Jensen & Sindet-Pedersen 
1991, Misch et al. 1992, Widmark et al. 1997, Montazem et al. 2000), few 
studies have examined the occurrence and fate of osteocyte survival in bone 
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blocks grafted into the human jaw using quantitative histomorphometry 
(Blomqvist et al 1998).  
This study aimed to gain insight on the fate of bone grafts into the 
human jaw with emphasis on the survival of the osteocytes and graft vitality.   
 
Materials and Methods 
Patients 
Nineteen patients (15 men and 4 women) of ages ranging from 17 to 
57 years were included in the study. Patients selected had a severe defect in 
the anterior maxilla, with complete loss of the buccal plate which required 
regeneration with a bone block, of such dimension that the implant (and thus 
biopsy) would be placed in the grafted bone only.  Patients had a variety of 
causes for the loss of their teeth, ranging from trauma to periodontal disease. 
All nineteen patients were healthy and one of them (patient no. 1, see Table 
1) was a smoker.  
A clinical and radiographical investigation was carried out and the 
treatment fully explained.  Patients were scheduled first for the bone 
augmentation followed by a period of healing and eventually a second 
operation for biopsy taking and implant placement. All patients were willing 
to donate the tissue to be removed during implant surgery for histological 
examination. Eight patients gave informed consent to use tetracycline for 
bone labelling.  The bone labelling protocol consisted of one tablet of 200 
mg tetracycline (tetracycline hydrochloride, Katwijk Farma, Leiden, 
Netherlands) three times a day for 2 consecutive days, followed by 2 weeks 
without tablets and then a further 2-day course. Labelling occurred between 
one and two months prior to biopsy retrieval. 
Clinical procedure 
The bone augmentation procedure was carried out under local 
anaesthesia and in sterile conditions. The mental nerves were bilaterally 
marked after carefully studying the patients’ radiographs and palpation of 
the mental foramina. A partial thickness incision was made 10 mm apically 
of the margin between attached and loose gingiva of the lower incisors.  The 
partial thickness incision was then extended apically until approximately 0.5 
–1.0 cm below the apex of the lower incisors where a full thickness flap was 
then made.  The symphyseal bone was fully visualised and a bone block was 
Monocortical bone block in human jaw 
 23
cut with ample irrigation with a thin stainless steel bur.  The two holes for 
fixation in the defect site were also prepared while the block was in situ and 
a countersunk provided so that the head of the screw was level with the graft 
surface.  The block was then lifted from its site by gentle easing with an 
osteotome and hammer.  The donor site was filled with bioactive glass 
particles (Biogran®, Orthovita, USA) and closed in two stages, a deep 
periosteal layer and a superficial mucosal layer, in order to avoid 
postoperative bleeding and any wound dehiscence as a result of swelling. 
The defect site was prepared by opening an adequate full thickness 
flap. The defect site was thoroughly cleaned in order to remove inflamed or 
infected tissue. The bone block was reshaped to fit the defect site and then 
fixed to it via two screws. (Fig 1a,b).  The graft was then covered with a 
resorbable membrane.  Usually the membrane chosen was Biogide® 
(Geistlich, Wohlhazen, Switzerland) but in two cases a non-resorbable 
membrane was used: in patients no. 1 and 4, a PTFE membrane (Gore, 
Flagstaf, Arizona, USA) was used. The flap was then closed over the bone 
graft in order to maintain the blood supply and sutured carefully in order to 
completely seal the wound.  The temporary prosthesis was altered to avoid 
loading of the graft. The sutures were removed one week later. Implants 
were placed 2.5 to 7 months later. During osseointegration of the implants, 
loading was again avoided by altering the temporary prosthesis.  
Biopsy procedure 
At the time of implant placement, the biopsies were taken 
exclusively from the grafted bone area (Fig 1c). An initial preparation for the 
implant was made with a hollow trephine burr (ITI- Straumann, Switzerland) 
of 2.8-mm outer diameter and with copious irrigation. The biopsy was then 
the material from the inner core of the trephine burr.  In this manner, a 
biopsy of approximately 2.5-mm diameter and 8-10 mm long was obtained, 
(see Fig 2a, b).  The biopsy was carefully pushed out of the trephine burr by 
using a specially designed instrument provided by the manufacturer.  The 
apical part of the biopsy was labelled by black indian ink, for orientation 
during histology. 
Histology 
All biopsies were immediately fixed in 4% formaldehyde solution in 
0.1 M phosphate buffer (pH 7.3) at 4°C for 24 hours (see also Tadjoedin et 
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al. 2000). They were then rinsed 3 times with 0.1 M phosphate buffer and 
finally stored at 70% ethanol at 4°C, until ready to be embedded.  All 19 
biopsies were cold embedded in methylmethacrylate with 20% plastoid. 
Undecalcified, five microns thick sections were made along the axis of the 
biopsy using a Jung K microtome.  Four groups of five consecutive sections 
were cut, with a distance of 225 microns between each group. The first and 
second sections from each group were stained with Goldner’s trichrome 
method (Romeis 1989). This procedure stains osteoid and other 
demineralised bone matrix red, mineralised bone matrix green and 
nuclei blue /black.  The third section of each group was used to identify 
osteoclasts using TRAP (Tartrate Resistant Acid Phosphatase) (Van de 
Wijngaert & Burger 1986) stain, modified by addition of 3 mM polyvinyl 
alcohol (Sigma P 8136, Mw = 30-70 kD) to the incubation medium and 
counter stained with light green.  TRAP- positive cells stain red while 
mineralised bone matrix and connective tissue stain green. Finally, one 
section of each group was left unstained for fluorescence microscopy in 
order to see the tetracycline labels, while the fifth section served as reserve.   
 
                          
Fig 1a-c: Cross- section of maxilla showing the defect, position of the graft and taking of the 
biopsy.  
a. A defect has developed on the buccal aspect leaving insufficient bone for placement of an 
implant. b. The defect is augmented with a monocortical bone block from the symphysis and 
left to heal after immobilization with two screws. c. The screws have been removed after 
healing and the biopsy is removed from the original graft with a trephine burr. 
 
Histomorphometry 
A Leica DM RA microscope connected to a computer using an electronic 
stage table and a Leica DC 200 digital camera were used for 
histomorphometrical measurements. The computer software used was the 
Leica QWin© (Leica Microsystems Image Solutions) to process and measure 
the digitised image. This software allows selection of parts of an image by 
setting a threshold to the colour of the pixels, which can then be measured. 
A B C
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Fig.2a: Monocortical bone grafted into the maxilla on re-opening after 6 months healing (see 
black line for outline).  Note the biopsy cut with a hollow trephine burr, in situ. In this case, 
the biopsy did not initially come out with the trephine, but stayed in the maxilla and was later 
carefully removed. b: The biopsy removed from the augmented site. Bar =0.5 cm. 
 
Four evenly spaced sections (one from each group) from each 
biopsy were used for the measurements. In this manner, a clear view 
throughout the biopsy could be made and the measurement became more 
accurate, since it accounted for variation throughout different depths in the 
biopsy. All measurements were carried out at 200 x magnification in order to 
allow clear distinction between empty and full osteocyte lacunae. The 
sections stained with Goldner’s trichrome were used for the measurements 
of total bone volume, non-vital bone volume and osteoid volume.  These 
were measured by consecutive fields until the whole section had been 
quantified. The number fields varied between 40 till over 80 fields, 
depending on the length of the biopsy. The total (absolute) bone volume 
(BV) was calculated as the amount of mineralised (green) bone tissue as a 
percentage of the total tissue volume (TV), (thus BV/ TV x 100 %), 
according to Parfitt et al. (1987).  The mineralised bone tissue that contained 
areas of empty osteocyte lacunae was defined for this study as the non-vital 
bone (NVB). NVB was expressed as percentage of the total tissue volume 
(NVB/ TV x 100 %).   The measurement of this volume was made semi-
automatically at the same time as the BV measurement, by outlining the area 
of empty osteocytes lacunae.  
A B
Chapter 2 
 26
The absolute osteoid volume was the total area of osteoid as a 
percentage of the total tissue volume (OV/ TV x 100 %).  TRAP- stained 
sections, consecutive to the Goldner stained sections were used to identify 
areas of TRAP positive cells and Howship’s lacunae and to measure the 
resorption surfaces (RS). The RS was defined as the scalloped surface and 
was expressed as a percentage of the total bone surface (RS/ BS x 100 %).  
Where applicable, fluorescent (tetracycline) labels were measured in 
unstained sections using an excitation wavelength of 354 to 425 nm and 
emission wavelength of 470 nm. The average distance between two labels 
was calculated by measuring the total area between the two bands and 
dividing it by their average length. Ten consecutive double labels were 
measured, when possible from the same section, and the average calculated. 
The MAR (mineralisation apposition rate) is the average distance between 
fluorescent bone labels divided by the number of days between the two 
courses of the tetracycline and is expressed as µm/day. 
Statistical analysis 
All data were analysed using SPSS for Windows 9.0.  The non-
parametric, one-sided Spearman’s correlation test was used to examine the 
correlation between healing time and histomorphometry volume. The data is 
presented as means and standard deviations. Significance was accepted when 
p<0.05. 
 
Results 
Clinical 
All 19 grafts were successfully integrated, providing sufficient bone 
for implant installation. They showed no resorption around the head of the 
fixation screws. One patient (no. 4), in whom a non-resorbable membrane 
was used, experienced a small membrane exposure. The membrane was then 
removed and no further symptoms were noticed. One patient (no. 7) had an 
allergic reaction to the suturing material (Vicryl), which once removed, 
resolved spontaneously.  One patient had paraesthesia of the upper lip, which 
recovered only partly. All 19 implants were eventually restored with a cast 
abutment and a cemented crown.  There have been up to the time of writing 
this paper, 6 months or more after fitting of the prosthetic work, no further 
complications. 
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Histology 
All sections contained varying amounts of vital and non-vital bone tissue, 
compact osteonic bone and trabecular bone.  The amounts of vital and non-
vital bone varied considerably between individuals. Bone classed vital (with 
fields of empty osteocyte lacunae), was predominantly of the lamellar type 
and was in contact with, or completely surrounded by vital bone (Fig. 3a). 
The vital bone was composed of both lamellar and woven bone. Using 
polarised light microscopy, the margin between the vital and the non-vital 
bone coincided with an abrupt change in the orientation of the lamellae (Fig 
3b). Very little qualitative difference could be found between biopsies of 
different healing times by description of the histology alone. 
The amount of osteoid also varied between biopsies (see Table 1).  Osteoid 
formation was particularly prominent in highly vascularised tissue. New 
bone was also formed within non-vital bone around the Haversian canals 
(Fig 4). All the tissues were free of inflammatory cells. Bone marrow was 
strongly vascularized and contained fat cells. 
Resorption sites could be easily identified in the TRAP stained sections, 
which identified location of osteoclasts.  The resorption sites were scattered 
and occurred predominantly in the non-vital bone, although no specific 
measurements were carried out in order to quantify this. 
The dynamics of lamellar bone formation were followed by tetracycline 
labelling, given two months before biopsy retrieval. Of the 8 patients who 
received tetracycline, one could not be measured because no discrete 
fluorescent bands were found, but rather a diffuse label. This resulted from 
the patient not following the labelling protocol accurately. Of the seven 
remaining patients, the double labels varied in length from short to long 
labels. The overall distribution of labels was similar in all cases. The non-
vital bone contained no tetracycline labelling. 
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Fig. 3a. Non-vital bone (within dotted line) surrounded by vital bone. Note new bone 
formation (O= osteoid) taking place, as indicated by black arrows. M= marrow, Ocy= 
osteocytes , EL= empty lacunae. Goldner’s trichrome staining. Magnification x 200 
 
Fig 3b. Polarised light microscopy of the same section as in Fig 3a. Areas of bone with empty 
osteocyte lacunae (within dotted line) and abrupt changes in orientation of lamellae (white 
arrows) were considered to be grafted bone that had become non-vital after grafting. 
Magnification x 200 
 
Fig 4. Vital bone containing osteocytes (arrows) in the inner core of an osteon, surrounded by 
non-vital bone (NVB), suggesting that the non-vital bone was recolonised by blood vessels 
(BV) and osteogenic cells via the Haversian canal. Goldner’s trichrome staining.  
Magnification x 400. 
 
Histomorphometry 
The absolute total bone volume (BV) (% of the total tissue volume) ranged 
from 27% to 57 % with an overall average of 41%. The percentage of non-
vital bone (NVB) varied from under 1% to 34 % with an overall average of 
11% of total tissue volume. The average vital bone volume between all 
patients was 30%. The volume of vital and non-vital bone of all the patients 
and the time of healing is presented in Fig. 5 and in Table 1. The relative 
NVB volume (NVB as % of total bone volume) varied from 87%, (in patient 
BV
NVB
4 
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no.13), to 2.5% (in patient no. 3). The NVB significantly decreased with 
increasing time of healing (r = -0.44, p < 0.05) (Fig 6). 
 
 
Table 1- Results of histomorphometry means. (BV= Total bone volume, NVB= Non-vital 
bone, OV= Osteoid volume, RS= Resorption surface and MAR= Mineral apposition rate.) 
Pat. Age 
yrs 
Sex Time
mths 
BV 
% 
NVB 
% 
OV 
% 
RS % MAR 
µm/day 
1 31 M 7 50.9 5.1 0.8 0.2  
2 17 F 4 55.3 18.4 0.8 0.2 1.3 
3 17 M 6 27.3 0.7 0.3 0.4  
4 52 F 5 30.1 2.6 0.7 1.4  
5 32 M 6 57.1 2.1 1.6 1.8  
6 36 M 4 42.5 3.3 1.8 1.7  
7 30 M 3 49.4 10.1 1.1 0.5  
8 33 F 4 46.7 4.7 1.6 0.6  
9 59 M 3 37.7 27.7 0.5 1.5  
10 49 M 4 36.7 4.8 1.0 1.2  
11 18 M 3 30.8 3.1 0.9 0.8 1.6 
12 22 M 4 29.4 14.7 1.2 1.2 1.7 
13 25 M 2.5 39.3 34.2 0.9 0.6  
14 55 M 3 41.2 4.1 1.4 0.5 0.7 
15 37 M 4 30.1 20.1 0.3 0.2 1.5 
16 17 F 3.5 54.0 22.4 0.9 1.1 1.4 
17 18 M 5 45.3 1.1 1.6 1.2  
18 34 M 3 37.8 18.2 0.8 1.2 2.3 
19 52 M 6 38.3 13.1 0.6 0.4  
Mean 33  4.2 41.0 11.1 1.0 0.9 1.5 
 
The osteoid volume (OV), expressed as a percentage of the total tissue 
volume (OV/TV x 100%) ranged from 0.3% to 1.8% (Table 1). The mean 
osteoid volume throughout the patients was 1.0 % ± 0.5. No correlation was 
found between the time of healing and the amount of osteoid   (data not 
shown).  
The resorption surface varied among patients from 0.2% to 1.8% of the total 
bone surface.  The average resorption was 0.9% ± 0.5 of the total bone 
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surface. (No correlation was found between resorption surface and the time 
of healing (data not shown).  
Finally, the mineral apposition rates (MAR) of seven patients are 
summarised in Table 1.  The MAR results varied from 0.7 to 2.3 µm/day. 
The overall average MAR of all patients was 1.5 µm/day ± 0.4.  All patients 
who received the tetracycline bone labelling had a short healing period 
(between 3 and 4 months). 
 
Discussion 
Our clinical findings show that 2.5 to 3 months after grafting the grafted 
bone had integrated with the original maxillary bone and was stable enough 
to be implanted without clinical complications. Histologically however, at 
this time the grafted bone contained substantial amounts of non-vital bone. It 
is not clear how long osteocytes survive once separated from their blood 
supply. Ellegaard et al. (1975) reported that one week after grafting of fresh 
cancellous jaw bone into furcation defects of monkey molars,  most 
osteocyte lacunae were devoid of cells.  A histological study in human 3-5 
cm sized rib bone fragments grafted submuscularly and retrieved one week 
later showed that 'more than 50% of the osteocytes retained their basophilic 
staining' (Chugh et al. 1998), implying that almost 50% of the osteocytes did 
not survive. In contrast, rat osteocytes maintained a normal morphology after 
grafting autologous fresh ribs into the mandible and examined at days 5- 84 
(Kamijou et al. 1994). More recent developments in orthopaedic and 
maxillofacial surgery have furthermore shown that vascularised grafts 
perform better than similar free grafts (Moran & Wood 1993, Goldberg et al. 
1987). Berggren et al. (1982) showed in a study in dogs that the osteocytes 
and osteoblasts can survive up to 25 hours of ischaemia if the grafts are 
stored in a cold culture solution followed by microvascular anastomoses. 
The survival of the osteocytes may therefore be partly explained by the 
revascularisation of the grafts. Our findings agree with the data of Ellegaard 
et al. (1975) and Chugh et al. (1998) illustrating that after disruption of the 
blood vessels many osteocytes in free, human chin bone blocks do not 
survive grafting.  
It has been stated that dead bone may be prone to fracture (Goldberg et al. 
1987). From a clinical point of view it would seems important to wait for 
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non-vital bone to be replaced by vital bone prior to implant loading, since 
vital bone has better mechanical characteristics  (Goldberg et al. 1987). 
 
 Fig. 5- Vital and non-vital bone as percentage of total tissue volume.  
 
Fig. 6 - Non-vital bone as percentage of total bone volume relative with time.  
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In this respect, the rate by which the non-vital bone is resorbed by osteoclast 
activity followed by bone formation is an important factor for 
osseointegration of implants. Recent data suggests that osteocytes may be 
involved in recruiting osteoclasts or modulating osteoclast activity by 
secreting signalling factors, such as nitrogen oxide, prostaglandins (Klein 
Nulend et al. 1995), osteoprotegerin, M-CSF and RANKL  (Zhao et al. 
2002) or factors related with the apoptosis pathway (Bronckers et al. 1996, 
Verborgt et al. 2000) induced by ischaemia (Kikuyama et al. 2002). The 
vitality of osteocytes in the graft may therefore be one factor to account for 
in remodelling of the bone graft.  It is reported by some authors that non-
vital bone is resorbed less easily by osteoclasts than vital bone. Kamijou et 
al. (1994) showed  that rat  rib bones, devitalised by freezing and grafted into 
the mandibles did not exhibit resorption, even after 84 days while in the 
control ribs,  where the osteocytes remained vital the majority of the rib bone 
was replaced by new bone, as early as 14 days. In contrast, other authors 
reported that after devitalisation of bone (by boiling or freezing bone 
fragments prior to grafting) the resorption was not greatly affected compared 
with resorption of vital bone (Ellegaard et al. 1975; Kingsmill et al. 1999). 
This is in agreement with the present study. We found a gradual decrease of 
the amount of non-vital bone (by osteoclastic activity) with increasing time 
of healing. Our results also suggest that the non-vital bone is fully replaced 
by new vital bone in approximately 7 months (see fig 6). 
In contrast to our findings, Blomqvist et al. (1998) reported that one month 
after grafting iliac crest- derived bone into the human sinus floor, 75 to 
100% of the osteocytes were vital and suggested that this was due to survival 
of the osteocytes. Their histological figures however show that a large 
number of these vital osteocytes were located in woven bone, suggesting that 
they were looking at bone that had formed since grafting (possibly from 
surviving osteoblasts and osteogenic cells) rather than true osteocyte 
survivals.  
There is increasing evidence that osteocytes are mechanosensitive (Klein-
Nulend et al. 1995) and as such play a crucial role in adaptive bone 
remodelling (Smit & Burger 2002). At the early stages of graft healing, 
osteocytes are still sparse in the grafted bone, since a large percentage of the 
bone is non-vital. It is important to consider how much vital bone is present 
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at the time of loading of an implant. If the implant is allowed to 
osseointegrate prior to loading during which time, remodelling of non-vital 
bone can take place. At time of loading the bone will be predominantly vital. 
Mechanical loading of this bone may then stimulate bone adaptation further 
by promoting bone deposition and bone resorption.  In short, the present 
study suggests that osteocytes in monocortical bone blocks of human chin 
are for the greater part unable to survive grafting. However, the remodelling 
that follows grafting is relatively quick and free of complications. Within 
approximately 7 months after grafting the bone is fully remodelled, vital and 
in principle able to adapt fully to the functional loads it must endure.  
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Abstract  
Porous β-phase tricalcium phosphate particles (pTCP) (Cerasorb®) was used in 
two patients to restore or augment alveolar bone prior to placement of dental 
implants. In one patient pTCP was used to fill a large alveolar defect in the 
posterior mandible after the removal of a residual cyst and in another patient to 
augment the sinus floor.  Biopsies were taken at the time of implant placement, 
respectively 9.5 and 8 months after grafting, and processed for hard tissue 
histology. Goldner-stained histological sections showed considerable 
replacement of the bone substitute by bone and bone marrow. In the 9.5 months 
biopsy of the mandible, 34% of the biopsy consisted of mineralised bone tissue 
and 29% of remaining pTCP, while the biopsy of 8 months after sinus floor 
augmentation consisted of 20% mineralised bone and 44% remaining pTCP. 
Bone and osteoid were lying in close contact with the remaining pTCP and 
were also seen within the micropores of the grafted particles. Tartrate resistant-
acid phosphatase (TRAP) multinuclear cells, presumably osteoclasts, were 
found surrounding, within and in close contact with the pTCP particles 
suggesting active resorption of the bone substitute.  Remodeling of immature 
woven bone into mature lamellar bone was also found. No histological signs of 
inflammation were detected. The limited data presented from these two cases 
suggests that this graft material, possibly by virtue of its porosity and chemical 
nature, may be a suitable bone substitute that can biodegrade and be replaced by 
new mineralising bone tissue.  
 
Introduction 
Application of dental implants is difficult in patients with large bone defects and 
insufficient bone volume. In these cases, it is required that the defect is restored 
or the bone augmented in order to obtain correct placement and sufficient 
retention of the implant. 
 Autologous bone from the iliac crest or chin is still the “golden 
standard” for bone augmentation (Block & Kent 1997, Misch et al 1992). 
However, there are problems associated with the harvesting of enough 
autologous bone to fill large bone defects (Kalk et al. 1996; Younger & 
Chapman 1989). Therefore, the search for a suitable biomaterial to be used as a 
bone replacement that allows bone regeneration and which would eliminate the 
need for an extra surgical site is continuing (Wheeler 1997).   
Bone regeneration with porous tricalcium phosphate. 
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 Most studies in human bone regeneration involve clinical observations 
and non-invasive techniques such as X-rays (Block & Kent 1998, Nicholas & 
Lange 1994). However, the most effective and conclusive way of evaluating 
how well these materials stimulate the formation of bone is through the 
preparation of histological sections from biopsies taken at the regenerated or 
augmented site. In the present study we have performed a histological, 
histomorphometrical and histochemical study of biopsies taken at 8 and 9.5 
months after grafting with a porous β-tricalcium phosphate (pTCP). 
Tricalcium phosphate is a biomaterial that has been studied extensively in the 
past (Saffar et al. 1990, Snyder et al 1984, Stahl & Froum 1986). Cerasorb®, 
however, is a pure β- phase tricalcium phosphate in a spherical shape and with a 
porous structure. The particles can be obtained in various sizes; the porosity is 
extensive and varies (according to the manufactures) between 5 and 15 µm in 
diameter.  The material has been shown clinically to biodegrade without adverse 
reactions (Wiltfang & Merten 1998).  We have examined by histology the 
performance of this material in two clinical cases: 1) a large bony defect in the 
posterior mandible after removal of a cyst and 2) the atrophic maxilla of an 
edentulous patient, augmented using sinus floor lifting. 
 
Materials and methods.  
Mandibular defect 
A 55-year-old man presented for implant consultation with a cyst in the partially 
edentulous posterior right mandible. After removing the cyst a large defect 
remained from positions 44 to 47, extending from the alveolar crest to 1 mm 
above the mylohyoid line (12 mm deep) and approximately 30 mm in the 
mesio-distal width and 7 mm in the bucco-lingual width. The defect was filled 
with packed Cerasorb® particles (diameter 1000-2000 µm, Curasan Pharma 
GmbH, Kleinostheim, Germany), mixed with sterile isotonic saline. The defect 
was then covered with a TefGen®  (non-resorbable) PTFE membrane and left to 
heal for 9.5 months. Healing was uneventful. Clinically, after nine and a half 
months the tissue appeared as densely packed graft particles adhered firmly 
together by a mineralised mass.  The augmented mass was biopsied by using a 
hollow trephine burr at the centre of the defect, at the site where a dental 
implant was to be placed.  
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Sinus floor elevation 
A 73-year-old man required a sinus floor augmentation procedure prior to 
placement of dental implants for stabilisation of his upper prosthesis. Both 
sinuses were greatly pneumatised, leaving an average residual ridge height of 2 
mm in the posterior maxilla.  Patient requested that no bone would be grafted 
from the iliac crest. The sinuses were thus augmented according to Boyne’s 
(Boyne & James 1990) method with Cerasorb®  (diameter 500-1000 and 1000-
2000 µm) particles that had been mixed only with sterile isotonic saline.  The 
augmented sites were then left to heal for 8 months. Healing was uneventful.  A 
biopsy was taken with a trephine burr at the time of implant placement from the 
position 26 where a dental implant was to be placed. 
Histological procedures 
Tissue processing and staining were carried out as reported (Groeneveld et al. 
1999a,b). Briefly, the biopsies were fixed in 4% formalin in phosphate buffer, 
processed without decalcification and embedded in methylmethacrylate (MMA) 
at 4oC. Sections (5 µm thick) were cut and stained according to Goldner’s 
trichrome method (Romeis 1968). Sections were stained for tartrate resistant 
acid phosphatase (TRAP; van de Wijngaert & Burger, 1986) for detecting 
osteoclastic activity. 
Bone Histomorphometry  
Bone histomorphometry was carried out using light microscopy at 
magnification of x 100 with an eyepiece containing a grid.  The grid, 
representing a test field, consisted of 10 equally sized and spaced lines dividing 
the test field in 100 sections. This test field was superimposed on consecutive 
fields of each specimen used.  Randomly chosen sections from each biopsy 
were used. The percentage of bone volume (Parfitt et al. 1987) and remaining 
pTCP was measured by counting the intersections of the grid, which hit (newly 
formed) bone, or (remaining) pTCP, respectively. In total ninety-eight test fields 
were measured from non-consecutive sections of the mandibular biopsy, while 
44 non-consecutive test fields were measured for the sinus augmentation site.   
 
Results 
Unstained sections of both biopsies showed the presence of the graft material as 
spherical calcified structures in various forms and sizes (Fig 1). The granules 
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showed a porous structure, with pores ranging between 5 and 15 µm diameter. 
The pTCP graft material was often in close contact with bone tissue. 
In sections stained with Goldner’s trichrome method most graft particles had 
been dissolved by the acid staining procedures, but their previous location could 
easily be recognised by their characteristic form and size (Fig 2). Large amounts 
of mineralised bone tissue were seen between and surrounding the remaining 
graft particles and occasionally also within the particles (Fig 3). The bone tissue 
was largely of the woven type, with osteocytes of normal appearance within 
lacunae, showing the vitality of the bone tissue. Large amounts of osteoid seen 
in close proximity to the mineralised bone suggested active bone formation (Fig 
4). A network of thin strands of osteoid material (red) or mineralised bone 
matrix (green) was often found within the remaining pTCP granules without 
any cells nearby (Fig. 5).  These strands had a diameter of approximately 1 µm, 
and seemed to fill many of the smaller micropores of the pTCP. In addition, 
isolated cells within larger pores, measuring about 10 µm, were often found to 
be dispersed throughout the pTCP material (Fig 3 insert). 
 Lamellar bone was found next to woven bone and was occasionally 
bordered by osteoid, thereby demonstrating mature bone formation. Lamellar 
bone was not, however, found within the pTCP particles.  
Multinuclear TRAP-positive cells were detected both along newly formed 
woven bone and in the surrounding tissue in close contact with the graft 
particles (Figs. 6a,b). Rarely, a TRAP-positive cell was found in the centre of 
the graft particle. 
The total (lamellar and woven) bone volume outside the pTCP granule was 34 
% and 20 % for the alveolar defect and the sinus augmentation, respectively 
(Table 1). After 9.5 months in the mandibular posterior site, 29 % of the total 
volume of the filled defect consisted of graft particles. After 8 months grafting 
in the sinus 44% of the graft still consisted of pTCP. Loose connective tissue 
with many fat cells filled the remaining spaces. 
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Fig.1 - Low power view of biopsy taken from the sinus elevation after 8 months of grafting. The 
porous structure of the graft (pTCP) is evident. The graft is in close contact with dense bone tissue 
(B). Unstained, plastic section (MMA) (Bar = 300 µm ). 
 
Fig. 2 - Low power view of biopsy taken from the sinus elevation after 8 months of grafting. Note 
the particular structure of the porosity of the pTCP material now filled in by (green stained) bone 
(B) and strands of (red stained) osteoid (sO). Goldner-stained deplastified section (Bar 160 µm). 
 
Fig. 3 - Low power view of biopsy from the mandible at 9.5 months.  The pTCP particle is closely 
surrounded by bone (B). The spherical particle outline can still be seen.  In the centre of the 
particle, bone is formed, surrounded by (red stained) osteoid (O).  Insert, shows higher 
magnifications of same tissue note individual cells within the graft are indicated by (C).  Goldner-
stained, deplastified section (Bar = 200 µm) Insert magnification X 300. 
 
Fig. 4 - High power picture of newly formed bone at the margin of the graft particle from the 
mandible biopsy. Bone (B), osteoid (O), osteoblast (Ob), osteocyte (Ocy), Goldner-stained, 
deplastified section (Bar = 40µm).  
  
Fig. 5 - High power view of biopsy from the mandibular defect. The bone (B) can be seen partly 
covered (red stained) by osteoid (O).  Thin strands of bone (sB) and osteoid (sO) can be seen in 
Bone regeneration with porous tricalcium phosphate. 
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the microporosities of the pTCP without the presence of cells. Goldner- stained, deplastified 
section (Bar = 30µm). 
 
Fig. 6 a, b - Multinuclear TRAP positive cells, presumably osteoclasts (Ocl) in close contact with 
a graft particle. TRAP-stain, with light green counter stain (a bar = 15 µm, b bar = 50 µm) 
 
 
Table 1 – Histomorphometry results of maxillary and mandibular defect augmentation.  
Biopsy Time of 
healing 
Bone volume 
% 
pTCP Volume % 
Sinus floor lift 8 months 20 44 
Posterior 
mandible  
9.5 months 34 29 
 
Discussion 
Our two cases demonstrate that pTCP granules enabled new bone to be formed 
in a human bone defect as well as in the human sinus, a location where no bone 
was present before grafting. The presence of newly formed mineralised bone, 
lined at the surfaces with osteoid, demonstrated that active bone formation was 
still in process.  The presence of both immature woven bone and lamellar bone 
along with active osteoblasts and osteoclasts suggests that bone remodelling 
was still going on in the grafted sites. Overall, the histological picture suggests 
that immature woven bone was formed in the grafted site, which was later 
remodelled into lamellar bone.  
Bone formation in grafts is thought to occur via three mechanisms of bone 
deposition: 1, Osteogenesis, in which the graft contains viable osteoblasts or 
osteogenic-precursor cells that establish new centres of bone formation; 2, 
Osteoinduction, in which the graft induces the transformation of recruited 
precursor cells from the host into bone matrix producing cells, and 3, 
Osteoconduction, in which the graft acts as a scaffolding for deposition of new 
bone by adjacent living bone (Groeneveld et al. 1999a).  It seems most likely 
that the pTCP material used in our study works mainly by osteoconduction; i.e. 
by guiding osteogenic cells from existing bone. These osteogenic cells 
differentiate into osteoblasts, which form bone between the separate graft 
particles. However, some formation of bone and bone-like material was also 
taking place within the pores of the particles. The size of some of the pores 
within the particles is large enough to allow infiltration of osteoblasts or their 
Chapter 3 
 
 46
precursors.  We even found indication of infiltration of multinucleated cells 
(presumably osteoclasts) in these macropores, though this was seen rarely. We 
suggest that in these cases the porosity provided the right environment to allow 
infiltration by osteogenic precursor cells or osteoblasts and subsequently 
support the laying down of osteoid. It seems, therefore, that the potential for this 
graft to promote bone formation is determined, at least in part by its porosity. 
In addition to bone cells, a web-like structure of thin strands of osteoid-like and 
bone-like matrix became apparent within smaller pores of the graft particles, 
sometimes without the presence of any cells. This phenomenon may be 
explained by diffusion of soluble pro-collagen molecules and other extracellular 
matrix protein into these micropores of the particles, which later polymerise into 
larger fibrils and form an osteoid-like matrix. Such a phenomenon provides a 
connected bone tissue network, which eventually also turns into a mineralisable 
bone-like matrix.  This may improve the mechanical properties of the graft 
material, which is by it self quite brittle, and can also play a role in later bone 
formation and remodelling after degradation of the biomaterial.  Further 
investigation into the properties of the thin strands of osteoid-like and bone-like 
materials found within the microporosity of the graft is necessary in order to 
establish further the mechanisms of bone deposition in the pTCP particles.  
Electronmicroscopy may help to determine the nature of this matrix and it may 
also help to clarify the mechanism by which the pTCP material is removed from 
the grafted site. 
The frequent presence of TRAP positive cells along and within the graft 
particles suggests that one way of removing this material be through osteoclastic 
activity. The vacated space is then subsequently replaced by bone and marrow 
tissue. However, TRAP staining is a good but not exclusive marker for 
osteoclasts for human tissue (Kadoya et al, 1994, Athanasou & Path 1996). 
Other mechanisms (chemical dissolution or activity of multinuclear giant cells) 
can operate in the removal of the graft material.  
We found bone volume for the 9-½ months cyst site in the posterior mandible to 
be 34% and 20% for the 8-month sinus floor augmentation. However, it is well 
accepted that cyst defects regenerate with ease, even if the defect is left unfilled. 
The result for the sinus floor augmentation is therefore a much more important 
and meaningful value. In our department Groeneveld et al (1999) found values 
of bone volume for sinus floor regeneration after 6 months with autologous 
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bone to be of 26%, using the same techniques. Bone volume in normal (non-
reconstructed) human maxilla by these same researchers was found to vary from 
24-61%. The 20% bone volume obtained in the present study after 8 months is 
almost within this already wide range. However, a better study using a split 
mouth technique, is needed in order to properly compare the efficacy of this 
pTCP with autologous bone, the golden standard. 
In conclusion, the present two cases confirm the resorbability of this porous 
tricalcium phosphate graft material and its replacement by bone without adverse 
reactions. This material has shown the potential to be used as a bone graft 
material for sinus floor augmentation and for filling bony defects. However, 
firm conclusions and guidelines for healing times and clinical applications can 
only be given after prospective controlled clinical and histological evaluation. 
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Abstract 
Tricalcium phosphate has been historically a well-accepted material 
for bone augmentation. We examined the use of a porous β-tricalcium 
phosphate (100%) in a split mouth model for sinus floor augmentation. Five 
patients were treated bilaterally, receiving 1-2 mm sized β-tricalcium 
phosphate particles (Cerasorb®) in one side (test side) and autologous chin 
bone particles in the other (control side). Four other patients were treated 
with a unilateral sinus floor augmentation using 100% β-tricalcium 
phosphate (TCP) (no controls). Biopsies of the augmented sites were taken 
at 6 months. Histomorphometry measurements were carried out in order to 
quantify bone augmentation at the test and the control sides. 
The average bone volume formed in the augmented sinus at the 
control side was 41 % (32-56%) and 17  % (9-27 %) in the test side when all 
9 patients were included (statistically significant, p= 0.04).  When only the 5 
bilateral patients were included, mean bone volume of the test side was 19% 
(13-27%) which was also significantly different from the control side (p = 
0.009). Osteoid formation tended to be higher in the test side biopsies (1.3%) 
than in the controls (0.3%) (marginally significant, p = 0.1), indicating 
ongoing bone formation in the tricalcium phosphate material. The amount of 
lamellar bone at the test side was less than half the amount in the control 
side, indicating that remodelling had only recently started in the TCP-
augmented side. The resorption surface however did not differ significantly 
between the two sides.  
These histological results indicate that Cerasorb® is an acceptable 
bone substitute material for augmentation of the maxillary sinus. Due to the 
osteoconductive, but not osteoinductive properties of this material, the rate 
of bone formation is somewhat delayed in comparison to autologous bone. 
 
Introduction  
Implant procedures in the posterior maxilla often pose a problem 
due to insufficient bone volume. Fortunately, bone correction techniques 
such as the sinus floor augmentation (Boyne & James 1980) have made it 
possible to increase this area of the maxilla so that implants may be placed 
after all.  Autologous bone is still the most predictable material for bone 
augmentations, but it comes at a cost.  Donor site morbidity is often a 
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problem with bone harvesting techniques (Erbe et al. 2001), therefore the 
search for good substitutes continues.  Much research has been dedicated to 
bone alternatives, including the purely synthetic materials such as the 
calcium phosphates. The hydroxyapatites, the tricalcium phosphates (α and 
β-TCP) and even the dicalcium phosphates have received much attention 
(Bulcholz 2002, Cameron 1977, Driessens et al. 1992, LeGeros 2002). 
However, despite the extensive research since the early 1970s, there is still 
lack of clarity concerning these materials. Some of the calcium phosphates, 
such as the hydroxyapatites are non-resorbable or partially resorbable while 
the β-TCP is resorbable.  The use of resorbable materials is preferred since 
they will be in the long term replaced by bone, which is able to adapt to the 
loads it is exposed to. The tricalcium phosphates mostly behave as 
osteoconductive materials, which permits bone growth on their surface or 
into pores, channels or pipes (Albrektsson & Johansson, 2001). In a 
qualitative histological study of two cases we previously investigated a 
relatively new material, a porous pure β-tricalcium phosphate (Cerasorb®) 
(Zerbo et al. 2001). This particular TCP material (Merten et al. 2002, 
Wiltfang et al 2002) has not yet been extensively studied in humans. Szabó 
and co-workers have provided the only quantified study of this material in 
the human sinus floor augmentation procedure (Szabó et al. 2001). Their 
histomorphometrical results showed no significant difference in bone density 
volume between the Cerasorb®-augmented and the control jaw that had been 
augmented with autologous bone. Unfortunately however they did not 
clearly distinguish between the pre-existing residual bone of the jaw and the 
new augmented bone. In the present controlled prospective study we sought 
to examine this issue further by analysing separately the residual bone of the 
jaw and the new bone formed in the augmented sinus. We tested the 
hypothesis that augmentation with Cerasorb® produces a similar bone 
density volume as augmentation with autologous bone within the same 
healing time of 6 months. 
 
Material and Methods 
Patient selection 
Patients with good general physical and mental health were asked to 
take part in the study. The patients chosen were either completely edentulous 
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or edentulous in the post-canine region. Age of patients varied from 28 - to 
65 years with an average age of 52 years. Six patients were male and three 
female. Sinus floor augmentation was planned in those cases where the 
overall lateral alveolar bone height was less than 8 mm (vertical bone height) 
and where at the most inferior point of the maxillary sinus a minimum bone 
height of 4 mm was available. In this manner, the residual (original) bone 
(RB) height of the alveolar crest was responsible for the primary stability of 
the implant.  All patients required sinus floor augmentation and no other 
bony augmentation, which would then be followed in due time by placement 
of dental implants. Patients were excluded from research if their health was 
compromised (ASA III or IV  -American Society of Anaesthesiology) and if 
they were suffering from any drug abuse, including alcohol, or any 
significant systemic disease. Patients had good oral health and no active 
periodontitis. Patients selected were non-smokers or had stopped smoking at 
least 3 months prior to the first surgery and continued not smoking for the 
duration of the research.  
All patients were fully informed concerning treatment to be carried 
out and signed a written consent form. Approval for the research was given 
by the Ethical Committee of the Vrije Universiteit and the VU Medical 
Centre Hospital prior to commencement of research.   
Sinus floor augmentation 
Patients were given antibiotic prophylaxis prior to sinus floor 
augmentation surgery. The augmentation was then carried out according to 
Tatum (1986). The space created between maxillary alveolar process and the 
new sinus floor was filled with autologous bone harvested from the 
symphysis area, or the bone replacement, Cerasorb®, sized 1000 –2000 µm 
(pore interconnection 5-20 µm and 45-50 % porosity) Curasan AG GmbH, 
Kleinostheim, Germany.  The choice of whether the sinus (left or right) 
would contain the test substance (Cerasorb®) or autologous bone was 
determined randomly, using a randomised table. However, if one of the 
sinuses had a residual bone height less than 4 mm this side was used as a 
control. The bone grafted from the symphysis was harvested under local 
anaesthesia with a ITI explantation burr of 4.1 mm diameter (Straumann, 
Waldenburg, Switzerland).  The bone harvested was predominantly cortical 
and the size of graft chips varied. The TCP test material was mixed with 
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blood from the operation site prior to delivery into the opened sinus cavity. 
No membrane was used. Complete wound closure was performed with Gore-
Tex® sutures. Patients were examined one week later and sutures were 
removed. The grafted sinus was left to heal for 6 months. 
Tetracycline bone labelling 
Bone labelling was twice by an oral dose of 250-mg tetracycline, 4 
times a day during two days. Patients were asked to take the first dose 3 
weeks before dental implant placement and the second dose, 1 week before 
dental implant placement. 
Dental implant surgery and biopsy retrieval 
 Dental implant installation and biopsy retrieval were carried out 
under local anaesthesia. Vertical incisions were made in the buccal mucosa 
distally of the canines and connected with a horizontal incision at the top of 
the alveolar crest.  A full thickness flap was raised and mobilised for tension 
free closure. Bone was inspected and biopsies were taken with a 3.5 mm 
(outer) diameter trephine burr (inner diameter 2.5mm)  (Straumann, 
Waldenburg, Switzerland) at the dental implant sites of approximately 12-mm 
depth, with copious irrigation with sterile saline. One, two or 3 vertical 
biopsies were taken from each sinus at the site where dental implants would 
be placed. One lateral (horizontal) biopsy was taken from each augmented 
sinus from the lateral wall, in order to gain insight of the bone formation high in 
the augmentation space. The biopsies were used for bone histology and 
histomorphometric analysis. 
 After collection of the biopsy, ITI® full body screw (4.1 mm diameter) 
dental implants (Straumann, Waldenburg, Switzerland) were placed into the 
implant beds with considerable care. The flap was sutured with non-resorbable 
Gore-Tex® sutures. Sutures were removed after 7 to 10 days and provisional 
prosthetics were adapted to the new situation. Attention was paid to prevent 
premature loading of the dental implant. After a healing period of 4 months, the 
implants were loaded.  
Histological procedure 
The biopsies were immediately fixed in 4% formaldehyde solution in 
0.1 M phosphate buffer (pH 7.3) at 4°C for 24 hours. They were then rinsed 
3 times with 0.1 M phosphate buffer and stored at 70% ethanol at 4°C, 
without decalcification. The embedding procedure consisted of gradual 
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dehydration and eventually cold embedding (at 4 °C) in methylmethacrylate 
with 20% Plastoid N (nonyphenolpolyglycol-etheracetate) Röhm Pharma, 
Darmstadt, Germany. Five microns thick sections were made of the 
undecalcified embedded specimens, using a Jung K microtome.  Four groups 
of five consecutive sections were collected, with a distance of 225 microns 
between each group so that the block was cut to approximately half of its 
diameter. The sections were then stained for light microscopy as follows. 
The first and second section from each group were stained with 
Goldner’s Trichrome method (Romeis 1989). This stain will colour osteoid 
and demineralised bone matrix red, mineralised bone matrix green and 
nuclei blue /black.  The third section of each group was used to identify 
osteoclasts by staining for Tartrate Resistant Acid Phosphatase (TRAP) 
activity according to Van de Wijngaert & Burger (1986). The latter was 
modified by addition of PVA (polyvinyl alcohol, Sigma P 8136, Mw = 30-
70 kD) with a final concentration of 3.2 x10-3 mM and counter stained with 
light green.  TRAP-positive cells stain red while mineralised bone matrix 
and connective tissue stain green. The fourth section of each group was left 
unstained for fluorescence microscopy in order to see the tetracycline labels.  
The fifth and final section was  kept as reserve in the event of damage to one 
of the other sections. 
Histomorphometry  
The most intact biopsy from each sinus was chosen for the 
histomorphometry. Four evenly spaced-out sections (one from each group) 
were used for the measurements. The volume measurements of bone and 
osteoid volume were carried out at 100 x magnification. Measurements of 
the resorption surface were carried out at 200 x magnification for easier 
identification of osteoclasts and Howship’s lacunae. The sections were 
marked with pen in order to delineate the margin between the existing 
(residual) alveolar bone (RB) and the new (augmented bone) (NB). This 
delineation was made after carefully studying the pre- and post- 
augmentation radiographs in combination with the macroscopic and the 
microscopic appearance of the bone.  A Leica DM RA microscope 
connected to a computer using an electronic stage table and a Leica DC 200 
digital camera was used for histomorphometrical measurements. The 
computer software used to process and measure the digitised image was the 
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Leica QWin© (Leica Microsystems Image Solutions). Sections stained with 
Goldner’s Trichrome were used to measure total bone volume (BV) and 
osteoid volume  (OV) from both the residual bone (RB) and the new 
(augmented) bone (NB), respectively.  Four fields of RB and NB were 
measured consecutively from each section, starting at the imaginary line 
dividing the RB and NB and moving away from each other.  The fields 
measured were 1218 µm in width and 958 µm in length. From each biopsy 4 
sections were measured and the values were averaged. The total bone 
volume (BV) was calculated as the amount of mineralised bone tissue as a 
percentage of the total tissue volume (TV) as according to Parfitt et al. 
(1987), thus (BV/ TV x 100 %).  The osteoid volume was the total area of 
osteoid as a percentage of the total tissue volume (OV/ TV x 100 %). TRAP- 
stained sections were used to identify osteoclast cells and their Howship’s 
lacunae in order to measure the resorption surfaces (RS). The RS was 
defined as the surface of Howship’s lacunae and was expressed as a 
percentage of the total bone surface (RS/ BS x 100 %).  In order to establish 
the maturity of the new bone formed after 6 months, quantification of the 
amount of lamellar and woven bone was carried out. For this purpose, a grid 
was used at 100 x magnification and the points of intersection of lines were 
counted.  The total numbers of points within bone were counted, and the 
number that fell within lamellar or woven bone quantified. Polarised light 
was used in order to facilitate this distinction. The percentage of lamellar or 
woven bone was calculated as a percentage of bone. 
 In order to show the rate of osteoconduction it was decided to 
measure the height of the augmented bone. These measurements were made 
using an automatic stage table, which is able to accurately measure the 
distance between two points.  The distance between the highest point in the 
residual bone to the highest point of augmented bone was measured (Fig 1). 
Lastly, fluorescent (tetracycline) labels were evaluated in unstained 
sections using an excitation wavelength of 354 to 425 nm and emission 
wavelength of 470 nm. The average distance between two parallel labels was 
assessed by measuring the total area between the two bands and dividing it 
by their average length. This procedure was only performed in lamellar bone 
as in woven bone the labels are too diffuse to allow reliable measurements. 
Average distances between 10 consecutive double labels were measured, 
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whenever from the same section and then the overall average calculated. The 
MAR  (mineralisation apposition rate) is the average distance between two 
fluorescent bone labels divided by the number of days between both courses 
of the antibiotic and expressed as µm/day.  
Statistical analysis 
All data were analysed using SPSS for Windows, Version 9.0. The data is 
presented as means and standard deviations. The statistical test used was the 
paired Student’s T-test for the patients with control groups (n=5) and the 
independent T-test was used for all patients, including those without control. 
The significance was accepted when p<0.05. 
 
 
 
 
 
Fig 1A. Histological overview of 
biopsy taken from the sinus with 
line of delineation between residual 
bone and new bone as well as 
between new bone and the rest of 
the biopsy. Circles shows 
boundaries of two TCP particles. 
(original magnification x25). 
Fig 1B. Schematic diagram of the 
same biopsy. At the bottom the 
most coronal part of the biopsy 
where the residual bone (RB) of the 
maxilla is seen and at the top the 
most apical end of the biopsy 
ending in the sinus.  NB: the area 
of new bone deposition. Vertical 
line with arrowheads: height of the 
augmented bone. The green boxes 
depict the successive fields 
measured in each biopsy: Four in 
the RB and four in the NB. 
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Results 
Clinical results 
Six months after augmentation all patients had sufficient bone levels 
for placement of the implants, with adequate primary stability.  No implant 
failures were noted up to the time of completion of this manuscript (1-3 
years after retrieval of the biopsies).  Implants were left an average of 5 
months prior to preparation of the definitive prosthetics and loading.  
Fifty biopsies were retrieved from the augmented sinuses. Eighteen 
biopsies were of the sinuses augmented with autologous bone of which 5 
were lateral and 13 were apical biopsies, where implant fixtures were later 
placed. The remaining 32 biopsies were taken from sinuses augmented with 
the tricalcium phosphate material. Twenty-three of these were apical and 9 
were lateral biopsies. The biopsies varied considerably in length between 
patients, and the location from which they were retrieved varied from first 
premolar to the second molar position. Biopsies, especially those containing 
the tricalcium phosphate material, were often difficult to remove in one 
piece from trephine burrs. The test material was not only hard but also brittle 
and therefore had a tendency to shatter.  
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Fig. 2 Histological detail of bone formation within and around a TCP particle. Osteoblasts 
(arrows) are actively laying down osteoid (O).Within the pores of the TCP particle red-
staining osteoid (arrowheads) and green-staining bone (B) has been laid down.  Goldner’s 
Trichrome stain. Original Magnification x200. 
 
Histologic results 
The control sites, grafted with autologous bone, showed varying 
amounts of regenerated vital bone, containing lacunae with live osteocytes. 
Occasionally, areas containing empty osteocyte lacunae were found within 
the grafted part of the biopsies, which are probably remnants of the grafted 
bone (see e.g. Zerbo et al. 2003). The residual bone (RB) of the original 
maxilla, contained moderate quantities of osteoid, which was slightly more 
prominent in the new bone (NB) and in both RB and NB the bone was 
predominantly lamellar. Moderate numbers of multinucleated TRAP positive 
cells (considered to be osteoclasts) were found in both the RB and the NB. 
At the most apical end of the biopsy soft connective tissue was often found. 
The biopsies containing the test material varied considerably.  
Biopsies often fractured during sectioning making it very difficult to keep 
orientation optimal and especially challenging for the quantification. The 
residual bone (RB) was similar to that of the control side being 
predominantly lamellar in nature and exhibiting little osteoid or bone 
resorption. In the augmented area, bone formation was evident in all 
biopsies, although in some lateral biopsies it was very scarce. The amount of 
new bone in the apical biopsies decreased considerably with increasing 
distance from the RB.  The first few TCP particles, laying directly over the 
RB were often partially or even completely replaced by bone (Fig.2). The 
particles more apical to these were progressively less infiltrated or 
surrounded by bone.  The bone formation took place predominantly around 
and in-between particles and only when this was abundant, was bone 
formation also found within the particle. This bone was mainly of woven 
type and had been laid down in the porosity of the TCP material.  The TCP 
particles apical to the area of bone formation were infiltrated by 
undifferentiated cells and were surrounded by a fibrous-rich material and by 
blood vessels (Fig.3). No foreign body reaction or signs of inflammation 
were noticed.  
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TRAP-positive cells were found in close contact with bone but also 
with the TCP material. These TRAP-positive cells were predominantly at the 
periphery of the TCP particles but also often infiltrated within the particles 
(fig.4).  The occurrence of these TRAP-positive cells decreased with 
increasing distance from the original bone. 
The lateral test biopsies were generally quite short (< 3mm) and 
poor in quality. In some biopsies, formation of a new buccal cortex was 
seen, but biopsies usually fractured, loosing much information of the graft 
material. They therefore did not contribute much to the study. However, in 
the few lateral biopsies that were reasonably intact, bone growth and osteoid 
formation was seen. The most bone had formed immediately next to the 
reforming buccal cortex, decreasing towards the deeper part of the biopsy.   
In the lateral biopsy with autologous bone, live bone was seen 
surrounding some remaining transplanted pieces with empty osteocyte 
lacunae. Some soft tissue formation was also seen. Lateral biopsies were not 
further used for the histomorphometry. 
Histomorphometry 
One apical biopsy of each augmented sinus was measured, retrieved from all 
9 different patients, 5 bilateral and 4 unilateral, giving 5 control biopsies and 
9 test biopsies. The average height of new bone formed in the 6 months of 
healing using the TCP material was 3219µm ±1436, varying between 1926 
and 5945 µm, for all nine patients. The average length augmented with 
autologous bone was not significantly higher, at 3562 µm ± 1991 and 
varying between 993 and 6129 µm (n=5). 
The percentage bone volume density of the residual bone (RB) in 
patients with bilateral grafts averaged 36% ± 10 for the control side (n=5) 
and 31% ±14 for the test side (n=5) (p=0.19). When the values for the 
unilateral biopsies were added an average of 31% ± 16 (tests, n= 9, p=0.5) 
was found. Therefore, in both the control and test sinuses, the bone volume 
density of the residual bone was similar indicating that the starting point for 
both materials was equal. In the augmented area, the control sinus 
(augmented with autologous bone) had an average bone volume of 41% ± 10 
(n=5). On the test side, augmented with the tricalcium phosphate material, 
the new bone volume averaged at 19 %±5 (n=5, bilateral patients) or 17 % ± 
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5 (n=9, all patients) (fig 5). This was significantly different from the controls 
(p=0.009 for n=5 and p= 0.04 for n=9). 
 
 
Fig.3 A TCP particle found in the more apical part of a biopsy shows no bone formation, but 
soft connective tissue (SCT) has been formed around and infiltrated into to the TCP particle 
(arrows). Light green staining. Original Magnification x100 
 
In the residual bone (RB), the osteoid volume was generally low. 
For the controls it amounted to 0.25 % ± 0.4 (n=5) versus 0.15 % ± 0.3 (at 
n=5) or 0.17 % ± 0.3 when all 9 test sinuses were included.  In the new bone 
the osteoid volume was higher, particularly in the test side. In the test side 
the osteoid volume of the new bone (1.27% ± 0.6, when n=5, and 1.31% ± 
1.0 when n=9) was more than triple that of the control sinuses (0.31% ±0.56, 
n=5). Due to large variation this difference was only marginally significant, 
at p=0.10. In the test side, osteoid volume in the new bone was seven times 
as high as that of the residual bone, a difference that was was significant (p= 
0.02) (Fig 6 ) 
 
SCT 
3 
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Fig. 4 Histological detail of osteoclasts in relation with TCP particle. Red stained, TRAP-
positive cells (Oscl) are found adjacent to the TCP material and to mineralised bone (B). 
TRAP-staining with light green counter stain. Original Magnification x100. 
 
The mean resorption surface in the residual bone of the test and the 
control sinus differed slightly (0.26 % ± 0.5 and 0.13% ± 0.2 of the bone 
surface) but this was not significant (Table 1). In the new bone, the mean 
resorption surface was 0.54 %± 0.4 in the control side and somewhat higher 
in the test side (0.92% ±0.5 for =5 or 0.75 % ±0.6 for n= 9)  (Table1). These 
values were not significantly different. 
The new bone in the control side consisted for 80% ±8 of lamellar 
bone, the remaining 20 % was woven. Of the new bone in the test side 
however, 26% ±11 was lamellar and 74% was woven. This difference 
between control and test side was significant (p = 0.01) 
The mineral apposition rate (MAR), a measure for the rate of 
formation of lamellar bone, did not differ between the test and control sides, 
with a mean of 1.3 µm per day (n=5) for the control side and 1.2 µm per day 
(n= 5) or 1.3 µm per day (n=9) for the test side. 
 
TCP 
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4 
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Table 1: Histomorphometry results:  
Patient Residual bone (%) New Bone(%) New 
(µm/day) 
N Se
x 
Ag
e 
Sinus BV OV RS BV OV RS MAR 
control 36 0.22 0.38 56 0.11 0.19 1.5 1 M 
 
59 
test 34 0.00 0.03 18 0.20 1.50 1.3 
control 30 0.01 0.00 49 0.06 0.95 # 2 M 61 
test 17 0.00 0.00 21 1.45 1.37 # 
control 34 0.96 0.00 33 1.31 0.96 1.0 3 F 51 
test 21 0.73 0.00 13 1.07 0.19 1.2 
control 53 0.04 0.28 32 0.02 0.20 1.0 4 M 50 
test 56 0.01 0.00 17 2.16 1.14 1.2 
control 26 0.00 0.00 38 0.07 0.41 1.8 5 F 48 
test 24 0.00 1.27 27 1.47 0.40 1.0 
Average 
n=5 
Contr
ol 
36 ± 
10 
0.25 ± 
0.41 
0.13 ± 
0.19 
41 ± 
10 
0.31 ± 
0.56 
0.54 ± 
0.39 
1.3 ± 
0.40 
Average 
n=5 
Test 31 ± 
14 
0.15 ± 
0.29 
0.26  
±0.51 
19 ± 
5 * 
1.27 ± 
0.64** 
0.92 ± 
0.53 
1.2 ± 
0.11 
6 M 56 test 25 0.03 0.31 15 3.46 1.50 1.5 
7 M 50 test 25 0.25 0.00 9 0.70 0.00 1.1 
8 M 28 test 57 0.49 0.00 13 0.34 0.00 1.1 
9 F 65 test 16 0.00 0.75 19 0.92 0.63 2.3 
Average 
n=9 
Test 31 ± 
16 
0.17 ± 
0.27 
0.26 ± 
0.46 
17 ± 
5  * 
1.31 ± 
1.01 * 
0.75 ± 
0.64 
1.3 ± 
0.41 
 
BV= bone volume (%), OV Osteoid volume (%), RS= Resorption Surface (%), MAR mineral 
apposition rate (µm/day).*different from control value, p<0.05; **,different from residual 
bone, p<0.05. # the MAR was not measured for patient no 2 since this patient forgot to take 
the tetracycline. 
  
Discussion 
  This histological study aimed to compare the quantity and quality of 
bone formed after augmentation with TCP (Cerasorb®), with bone formed 
using autologous bone. After 6 months of healing, bone formation was seen 
in all augmented sinuses. The TCP material (Cerasorb®) was capable of 
producing bone height similar to the control group (the autologous bone 
graft). Both methods lead to augmentation in height of 3.2 to 3.5 mm of bone 
in the 6 months period. There was however a difference in the quality of the 
bone. In the controls, augmented with autologous bone, the new bone was 
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mostly lamellar (80%) and mature in type. In the TCP sites, this was much 
more immature and predominantly woven (74%) in type. In addition, the 
bone density volume was lower in this group. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5 Bone volume density of the new bone (NB) of the control and test sinuses, 6 months 
after grafting (percentages of total tissue volume). Data shown is for the all 9 patients. A line 
connects the result of test and control sinus of the bilateral patients. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.6. Osteoid volume of residual bone and new (augmented) bone at 6 months healing after 
grafting with either test or control material. Data shown is for all 9 patients (means and 
standard deviations). 
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Together these results indicate that this TCP behaves as an osteoconductive 
material, that is when the material acts as a scaffold into which there can be 
cell in-growth and eventual bone formation.  This is a relatively slow process 
by which bone formation takes place in one direction, which is from the 
original residual bone surface into the material. From our results we estimate 
0.5 mm bone formation in height, on average, per month. The densest new 
bone was found directly adjacent to the pre-existing bone of the jaw, while 
in the apical part of the biopsies only cells without any bone matrix were 
seen infiltrating successive TCP particles. This was not seen in the control 
biopsies, augmented with autologous bone. In these, osteogenic cells had 
dispersed throughout the entire grafted site and had differentiated and 
promoted bone  deposition throughout the graft. Osteogenesis, taking place 
in the autologous bone graft, is therefore a much faster process than 
osteoconduction. This is reflected in the bone volume differences between 
the test and the control groups. 
Our results show that the osteoid volume in the augmented bone, particularly 
in the test side, was higher than in the residual bone. This indicates that the 
bone formation in the augmented site was still active in comparison with the 
residual bone, which had settled down to a normal but slow remodelling 
process. We also found that the osteoid volume in the TCP group 
(augmented bone) was higher than that of the autologous bone graft.  This 
may be explained by the different mechanism by which bone formation is 
taking place. In the control site, where osteogenesis occurred, the new bone 
had already reached maturity. The osteoid found in these sites was layed 
down in a lamellar manner and in less quantity than in the test site. This is 
reflected in the high percentage of lamellar bone and in the high bone 
volume. In the test site, a time of delay had occurred due to cell recruitment, 
migration into the osteoconductive material, and differentiation into 
osteoblasts prior to bone formation. Therefore at 6 months healing time, this 
has resulted in much osteoid, while the bone volume was still relatively low, 
and the bone tissue was predominantly woven in type. Bone resorption was 
low in all samples, indicating that the remodelling of bone was generally 
slow. This conclusion is substantiated by the MAR values, which give an 
indication of the speed of mineralisation of lamellar bone. As the MAR 
values did not differ between test and control groups, mineralisation of 
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osteoid occurred in a normal rate, also in the TCP-augmented sinus.
 Szabo and co-workers (2001) carried out a similar study with split 
mouth design in which the same TCP material was compared to autologous 
bone (harvested from the iliac crest). Their data shows that the sinus 
augmented with TCP contained slightly lower bone volumes (29% ±10) than 
the control sinus (37% ± 9) (data calculated from values given) but this 
difference was not statistically significant. In our study the bone volume in 
the test side was significantly lower than the controls. Szabo et al. also found 
predominantly lamellar bone in the test sinus while in our study we found 
predominantly woven bone suggesting that the new bone was less mature. 
Unfortunately, the paper by Szabo et al. does not mention which part of their 
biopsies was measured and if they separated the samples into new and 
residual bone. If the biopsies were measured as one piece without 
differentiation between existing residual and new bone, this might account 
for the higher bone volume and high amounts of lamellar bone in their 
results. A further important difference is that they selected patients who 
required a sinus floor augmentation in combination with an onlay plasty. 
This was required because, as stated in the paper  “the residual alveolar ridge 
was thinned to a fine edge in the horizontal and sagittal directions”. The 
authors mention that the cortical bone used for the onlay plasty was not in 
the biopsy sample; however, taking a biopsy from a knife-edge without 
including the cortical onlay is very difficult.  If the onlay bone was 
distinguished histologically from the original bone, the paper does not 
describe it. On the other hand, if the onlay of cortical bone was included in 
the sample, this would also influence the results positively.  We selected 
patients with a much wider alveolar ridge that did not require any sort of 
lateral augmentation, and separated the residual bone from the new bone. 
Therefore we assume that the present data better reflects the biological 
difference between autologous bone and bone substitute. 
 In conclusion, Cerasorb® has shown in this prospective comparison 
with autologous bone that it activates bone formation by osteoconduction, 
and that it resorbs to be progressively replaced by bone tissue.  Although the 
mechanisms of bone conduction and material resorption are still not fully 
understood, our histological observations clearly indicate that bone matrix is 
deposited within the pores of the TCP granules. Our data suggest that for this 
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treatment group, where primary stability is derived from the pre-existing 
bone of the jaw, this TCP material will provide adequate bone augmentation 
after sinus floor lifting provided that adequate healing time is allowed. Our 
hypothesis that Cerasorb® produces similar bone volume density to 
augmentations with autologous bone is not true at 6 months. However, our 
histological data from case study (Zerbo et al. 2001) in which 8 months were 
instigated and other histological findings from (as yet unpublished) data with 
longer healing times, suggest that the bone formation continues to take place 
after 6 months. Thus the bone volumes are likely to continue increasing and 
the Cerasorb® is progressively replaced if longer times are used. In larger 
defects, this material may benefit from mixtures with small amounts of 
autologous bone (see e.g. Tadjoedin et al. 2002) in order to maintain the 
healing time within acceptable limits.  
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Abstract 
We and others have shown earlier that porous β-tricalcium 
phosphate (TCP) (Cerasorb®) can be used in patients to augment the 
maxillary sinus floor prior to placement of oral dental implants. To better 
understand the transformation of TCP particles into bone tissue, we analyse 
here the appearance of cells with osteogenic or osteoclastic potential in 
relation to these particles. In biopsies taken at 6 months after sinus floor 
augmentation we observed bone growth into the TCP particles but also 
replacement by soft connective tissue.  To identify possible osteoprogenitor 
cells in this tissue, histological sections were immunostained with an 
antibody to Runx2/Cbfa1, an essential and early transcription factor for 
osteoblast differentiation. The cells osteogenic potential of cells was further 
confirmed by staining with for bone sialoprotein (BSP) and osteopontin 
(OPN) immunostaining. Other sections were stained for Tartratre Resistant 
Acid Phosphatase (TRAP) activity to identify cells with osteoclastic 
capacity.  
Runx2/Cbfa1 positive connective tissue cells were found in 
abundance throughout and around the TCP particles, even at a distance of 
several millimetres from the maxillary bone surface. About 95% of the cells 
found within TCP particles stained positive for Runx2/Cbfa1. Fewer cells 
stained positive for BSP and OPN, suggesting more mature osteoblastic 
properties. Mono- and binucleate TRAP-positive cells, but no multinucleate 
TRAP-positive cells osteoclasts, were found in the soft tissue infiltrating the 
TCP and or at the surface of the TCP particles. Both the Runx2/Cbfa1 
positive and the TRAP-positive cells decreased apically with increasing 
vertical distance from the maxillary bone surface.  
This data suggests that the TCP particles attract osteoprogenitor cells 
that migrate into the interconnecting micropores of the bone substitute 
material. The lack of large multinucleate TRAP positive cells suggest that 
resorption of the TCP material by osteoclasts plays only a minor role in its 
replacement by bone of the TCP by bone. Chemical dissolution, possibly 
favoured by a high cell metabolism in the particles, seems the predominant 
cause of TCP degradation. The abundance of Runx2/Cbfa1 positive cells 
would indicate that with a greater time of healing there will be further bone 
deposition into these particles.  
Osteoprogenitor cells infiltrating β-TCP particles.  
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Introduction 
Patients who have lost their natural dentition prematurely can be 
helped with the placement of implants in order to secure a dental prosthesis. 
However, the lack of posterior maxillary alveolar bone is often a problem. 
Insufficient bone height can however be corrected with procedures such as a 
sinus floor augmentation, in which the bone or a substitute material can be 
used to increase the height of bone of the posterior edentulous maxilla.   
In a previous paper we have investigated the ability of a porous β-
tricalcium phosphate (TCP) to generate bone in sinus floor augmentation 
(Zerbo et al. 2004). This material acted as an osteoconductive material, i.e. it 
allows osteoprogenitor cells to grow on its surface or into its porosity and 
differentiate into osteoblasts and thus bring about bone deposition ( 
Albrektsson & Johansson 2001). Significantly less bone was formed in the 
sinus augmented with the TCP particles than in the control sinus augmented 
with an autologous bone graft after 6 months healing. Bone had replaced 
TCP particles in the areas immediately apical to the residual (original) bone. 
However, further away from the original bone surface we observed large 
areas of the bone substitute material yet devoid of bone matrix, but 
containing undifferentiated soft connective tissue in-growth with many cells 
of uncertain capacity. In the present study we set out to investigate the origin 
and specificity of these cells in order to establish whether they show 
osteogenic potential.  
We also studied the mechanism for the biodegradation of the TCP 
prior its replacement by bone. Biodegradation of TCP is thought to happen 
in two ways: either by cell mediated resorption by osteoclast activity or by a 
process of dissolution by the interstitial fluid (Lu et al. 1998). To detect 
involvement of osteoclasts in TCP degradation in the present study we 
stained sections for tartrate resistant acid phosphatase (TRAP), a cytoplasmic 
marker to identify osteoclast-like cells.  
To analyse the presence of cells with osteogenic potential, 
antibodies to Runx2 or core binding factor alpha 1 (Cbfa-1) have been used. 
Runx2 /Cbfa-1 is a transcription factor, required for the activation of 
osteoblast differentiation (Otto et al. 1997, Byers et al. 1997) and is crucial 
for the regulation of genes responsible for the production of bone specific 
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proteins (Ducy et al.1997). Runx2 /Cbfa-1 regulates transcription of collagen 
type 1 (the most abundant bone matrix protein), osteopontin and bone 
sialoprotein, both non-collagenous proteins found in extracellular matrix of 
bone (Ducy et al. 1997, Rodan & Harada 1997). Without Runx2 /Cbfa-1, 
osteogenic cells cannot differentiate into osteoblasts. Also, collagen type I, 
OPN and BSP are not synthesised and bone will not be formed (Otto et al. 
1997, Komori et al. 1997).   To further identify cells of the osteogenic 
lineage (preosteoblasts, osteoblasts and osteocytes) we used antibodies to 
two proteins which are expressed early in bone formation: bone sialoprotein 
(BSP) and osteopontin (OPN), normally expressed in (pre) osteoblasts and 
osteocytes (De Oliveira et al. 2003, Malaval et al. 1999, Ganss et al. 1999, 
Kato et al. 2001). 
Our hypothesis was that the connective tissue cells found at 6 
months of healing within and surrounding the TCP particles used for sinus 
floor augmentation, are osteoprogenitor cells or differentiating osteoblasts. 
In the long run these cells may further contribute to bone formation. 
Furthermore, we hypothesised that osteoclast activity plays a major role in 
the breakdown of the TCP material. 
 
Materials and Methods 
Clinical procedures 
Selection of patients for clinical and histological study has been described in 
full in Zerbo et al. (Zerbo et al. 2004). In short, healthy patients requiring 
sinus floor augmentation prior to implant placement with a residual ridge 
between 4 and 8 mm in height were selected. Sinus floor augmentation 
according to Tatum (1986) was performed with a porous β-tricalcium 
phosphate (TCP) (Cerasorb®, particles sized 1000 –2000 µm, with 
interconnecting micropores of 5 to 20 µm, Curasan AG GmbH, 
Kleinostheim, Germany) and left to heal for 6 months. Biopsies were 
retrieved at the time of implant placement by preparing the implant bed with 
a hollow trephine burr (3.5 mm outer diameter) and keeping the inner core as 
the biopsy sample. After collection of the biopsy, ITI® full body screw (4.1 mm 
diameter) dental implants (Straumann, Waldenburg, Switzerland) were placed 
into the implant beds. Approval for the study was given by the Ethical 
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Committee of the Vrije Universiteit and the VU Medical Centre Hospital 
prior to commencement of research and all patients were fully informed. 
Fixation and embedding 
Biopsies from 3 patients were fixed for 24h in 4% formaldehyde in 
0.1M phosphate buffer solution. One biopsy from each patient was 
decalcified in 5 % EDTA, 1% formaldehyde at pH 7.3 during 6 weeks. After 
rinsing with 0.1 M phosphate buffer these biopsies were dehydrated through 
ethanol 90% and 100% and cleared twice in xylene, and finally embedded in 
molten paraffin at 52oC. Sections 5-6 µm thick were cut with a microtome, 
placed on a polylysine coated glass slide and dried overnight in a 37oC-40oC 
stove to be used for immunohistochemistry (see below).  
Biopsies from 9 other patients were processed undecalcified and 
embedded in MMA as described in detail in Zerbo et al. (2004). In short, they 
were dehydrated in alcohol and embedded at 4˚C in 80% MMA and 20 % 
plastoid. Five microns thick sections were cut with a Jung K microtome and 
left to dry at 37oC for 24 hours, to be used for Goldner or TRAP staining (see 
below). 
Goldner staining  
 MMA-embedded sections were stained with Goldner’s trichrome 
method to detect bone and osteoid (Romeis 1989). This stain results in green 
staining for the mineralized bone and red for unmineralised matrix- osteoid.   
TRAP staining  
Tartrate resistant acid phosphatase (TRAP) staining was carried out 
according to the method described by (Van Wijngaert & Burger 1986). 
Sections were counterstained with light green.  This procedure stains cells 
with TRAP activity (osteoclasts and osteoclast-like cells) red, while 
mineralised bone matrix and connective tissue stain light green. 
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Fig. 1a: Undecalcified Goldner-
stained section showing bone 
formation in and around TCP 
particles. B, immature woven 
bone stains blue-green; O, 
osteoid, red; TCP, tricalcium 
phosphate material infiltrated 
with connective tissue cells, the 
nuclei of which stain red.  
(Original magnification x 100). 
Insert in Fig. 1b 
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Fig. 1b: High magnification of 
Fig. 1a. Note cell infiltration in 
the porosity of TCP material 
(*) as indicated by the red cell 
nuclei. The hash (#) indicates 
the TCP material that has been 
removed during the 
histotechnical procedure. 
Large arrow indicates osteoid 
(red) formation within the TCP 
particle. Note that bone has 
been deposited immediately 
against TCP material (double arrows)(Original magnification x 400).
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Fig. 2 High magnification of TRAP staining. The arrows show the TRAP positive mono- and 
bi-nucleated cells (red) in the soft connective tissue (SCT) that has infiltrated the TCP 
particle. (Original magnification x 400). 
Fig. 3. Number of TRAP positive cells in or around three consecutive TCP particles moving 
from coronal to apical, thus further away from the residual bone surface.  Measurements 
were performed for positive cells found in the soft connective tissue (SCT) within particles or 
at the surface of the particle (surface). The amount of bone surrounding the particle is also 
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indicated. Note that both the number of TRAP positive cells and the amount of bone decrease 
apically. Values are means and s.d. of nine patients.  
 
Immunohistochemistry 
Immunostaining techniques for Runx2 /Cbfa-1 were identical to 
those reported by Bronckers et al. (2003). In brief, sections were 
deparaffinised in xylene and rehydrated in successively decreasing grades of 
alcohol solutions. For the ABC peroxidase staining a 0.3% H2O2 in ethanol 
rinse was used for 3 minutes to destroy endogenous peroxidase; then sections 
were rinsed in 0.1 M phosphate buffer and blocked with 30 % normal horse 
serum (30 min). The primary antibody to Runx2/Cbfa-1 (mouse recombinant 
monoclonal antibody Pebp2αA, a gift from Dr K. Sasaguri, Kanagawa 
Dental School, Japan) was reacted overnight at 4 °C in a moist chamber at 
1:800 concentration. After rinsing, the sections were reacted with 
biotinylated horse anti-mouse IgG. After rinsing, this was followed by 
incubation with ABC peroxidase (Elite kit, Vector Labs, La Jolla, CA, USA) 
according to the manufacturer’s instructions. Developing was carried out 
with a DAB kit (Vector Labs, La Jolla CA, USA), counterstaining was 
performed with methyl green and the slides were mounted in 50% glycerol 
in PBS. Positive cells stained brown; negative cells only showed blue/green 
nuclei but no brown cytoplasm. 
 Immunostaining for BSP and OPN was performed in a similar 
procedure as for Runx2 /Cbfa-1with the following exception.  A pre-
incubation with hyaluronidase at 1 mg/ml phosphate buffered saline (PBS) 
was used for 1 hour at 37C° followed by a 10 min treatment with hot (100 
C°) citrate buffer (0.1M, pH 6) prior to incubation with the primary 
antibody. BSP mouse antihuman monoclonal antibody (Immunodiagnostik 
AG Benstein, Germany, see Ibrahim et al. 2000) was used to stain for 
intracellular bone sialoprotein at 1:1000 concentration. The mouse antirat 
osteopontin monoclonal antibody, used at 1:600 concentration, was 
developed by Solursh and Franzen (MPIIIB 101) and obtained from the 
Developmental Studies Hybridoma Bank, developed under auspices of the 
NICHD and maintained by the University of Iowa, department of Biologcal 
Sciences Iowa City, IA52242. 
As positive control, embryonic human jaw tissue (16 weeks intra-uterine) 
was used (for details, see Bronckers et al. 2003). These embryonic jaws were 
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largely made up of rapidly developing woven bone. Positive Runx2 /Cbfa-1 
staining was present in osteocytes, osteoblasts and a large periosteal layer of 
undifferentiated osteogenic cells. Runx2 /Cbfa-1 staining was also found in 
several non-skeletal tissues such as salivary ducts and endothelial cells in 
capillary walls (data not shown). Staining for BSP and OPN was seen in 
osteoblasts, young osteocytes and in the preosteoblastic layer (data not 
shown). For negative controls, normal mouse IgG (Vector Labs, La Jolla, 
CA, USA) replaced the primary antibody.  
Histomorphometry 
The relative bone volume in and around three successive TCP 
particles at increasing distance from the residual maxillary bone surface was 
scored in a semi-quantitative manner.  The bone was scored as +++ (> half 
of the particle surrounded by bone), ++ (< half of the particle surrounded by 
bone), + (some/ little bone) or – (no bone). The average of all the measured 
sections is shown in horizontal bars below figures 3 and 5.  
In similar TCP particles the numbers of positive cells (Runx2 /Cbfa-
1 or TRAP) in contact with TCP particles were counted. Positive cells were 
assessed initially in two different locations: 1, at the surface of the TCP 
particle; and 2, in the soft connective tissue (SCT) infiltrating the TCP 
particle. We further divided the latter for the Runx2/ Cbfa-1 counting in 
order to establish whether the positive cells were infiltrating as single cells 
or as a SCT mass. Counting was performed at 100 x magnification, again in 
3 successive particles at increasing distance from the residual maxillary 
bone. No attempt was made to quantify cells in-between particles. Three 
sections were counted per biopsy (one biopsy per patient) and values were 
averaged. Results of all three biopsies were expressed as mean and standard 
deviation. 
 
Results 
In line with our earlier study (Zerbo et al. 2004) bone growth had 
occurred primarily in-between particles (Fig. 1a). Within the particles, bone 
formation was only beginning. Despite lack of bone formation within the 
TCP particles, their infiltration by soft connective tissue cells was abundant 
(see insert Fig. 1b), also in areas distant from bone. 
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After staining for TRAP, osteoclasts were easily identified in the 
residual jaw bone as cells with a red cytoplasm located along the margins of 
bone and often adjacent to a characteristic Howship’s lacuna. TRAP positive 
cells were also found in the augmented site. These TRAP positive cells were 
predominantly found in the periphery of the TCP particles and in the soft 
connective tissue mass infiltrating the particles (Fig. 2). Generally these cells 
were small, containing only one or two nuclei. Giant cells were not 
observed. In the TCP particles osteoclastic cells were always accompanied 
by (TRAP negative) soft connective tissue cells. Fig. 3 demonstrates the 
number of TRAP positive cells counted in adjacent particles moving apically 
from the original bone. The number of TRAP positive cells infiltrating and 
in contact with the TCP particles decreased with increasing distance from the 
residual bone (apically). The amount of bone surrounding each particle also 
diminished in the apical direction (Fig. 3).  
 
Fig.4a Runx2 /Cbfa-1 staining of biopsy with TCP particle. Note bone tissue (B, 
light pink) and cell-rich soft connective tissue (SCT) which have formed between and around 
particles. Note positive staining of cells that have infiltrated into the particle, particularly it’s 
periphery. The centre of the particle does not (yet) contain cells. (Orig. magnification x 100).  
Runx2 /Cbfa-1 positive staining was found in abundance in bone tissue as 
well as the TCP material. Young active osteoblasts, cells adjacent to the 
osteoblastic layer (presumably preosteoblasts) and young osteocytes with 
SCT 
SCTB 
B 
TCP 
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abundant cytoplasm were immunopositive. In contrast, mature osteocytes 
with flattened shape and little cytoplasm did not stain, as reported 
(Bronckers et al. 2003).  
 
 
Fig. 4b  High power magnification of insert in Fig. 4a. White arrows mark some of the  
Runx2 /Cbfa-1 positive cells in the SCT or TCP. Note Runx2 /Cbfa-1 negative bi-nucleate 
cells (black arrows) that are possibly osteoclasts (see Fig. 2). (Orig. magnification x 400). 
 
Most cells found in the undifferentiated soft connective tissue (SCT) 
mass infiltrating and replacing the TCP particles were positive for Runx2 
/Cbfa-1 (Fig. 4 a, b). The number of positive cells decreased towards the 
middle of each particle, and also decreased in successive particles moving 
away from the residual bone (Fig. 5). As the total number of infiltrating cells 
also decreased apically, the percentage of positive cells was always very 
high, amounting to 95 % of all cells within and around the particles. Runx2 
/Cbfa-1 positive staining was also detected in endothelial lining of young 
blood vessels in the regenerated sinus floor. Control sections stained with 
non-immune IgG were negative (Fig. 4c). 
Osteopontin and BSP immunostaining was much more restricted 
than Runx2 /Cbfa-1; positive staining was noted in differentiating 
osteoblasts, active osteoblasts and in some young osteocytes. Positive cells 
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were often also found in the SCT mass but within a relatively short distance 
from bone (Fig. 6). Staining for BSP and OPN was also seen in relatively 
few (isolated) cells infiltrating the particles (see Fig. 6 for OPN staining; 
similar distribution was found for BSP, data not shown). 
Discussion  
The first aim of this study was to assess whether the connective 
tissue cells surrounding and infiltrating the particles were osteogenic.  
Therefore, we stained for the presence of Runx2 /Cbfa-1, an essential 
transcription factor for osteoprogenitor cells in the sequence of events 
leading to osteoblast differentiation (Rodan & Harada 1997). The Runx2 
/Cbfa-1 antibody used in this study has been shown to localise cells of 
chondrogenic and osteogenic lineage in rodents and human tissues 
(Bronckers et al. 2003). In the present study we confirm the expression of 
Runx2 /Cbfa-1 in (pre) osteoblasts and in young osteocytes of regenerating 
human maxillary bone. In addition, we present evidence that most cells 
around and infiltrating the TCP material express Runx2 /Cbfa-1. We did not 
find any histological evidence for cartilage formation or the presence of 
cartilage-like cells in our biopsies. The positive staining of OPN and BSP 
(markers for bone cells) in (pre) osteoblasts, young osteocytes and in some 
connective tissue cells around or in the particles furthermore suggests that 
these cells follow the osteogenic differentiation pathway (De Oliveira et al. 
2003, Malaval et al. 1999).  Thus, our findings are in agreement with the 
hypothesis that the connective tissue cells in and around the TCP particles 
found at six months after sinus lifting, are osteogenic and therefore have the 
potential to become osteoblasts. Based on these observations we speculate 
that in the ensuing months bone formation will proceed in the augmented 
sinus, thus further increasing bone height and bone volume. 
  These and previous data show that TCP particles in the human sinus 
act in an osteoconductive way. When TCP particles are implanted into the 
sinus, osteogenic cells start migrating from the existing bone surface in 
between and over the surface of the particles. Migration of these cells may 
be stimulated by components from the forming blood clot. Blood clots are 
composed largely of fibrin but also to a large extent of blood borne 
fibronectin, an adhesive glycoprotein, which connects integrin receptors of 
cell membranes with extracellular matrix molecules via – Asp-Gly-Arg – 
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(RGD) motives and guides cell migration (Anselme 2000). In adults, most 
connective tissue cells are bound to extracellular matrix and not very mobile. 
However, in wound healing, cells regain a high capability of migration, 
similar to embryonic tissues (Park et al. 2001). It is conceivable that 
undifferentiated (mesenchymal) cells migrate through a fibronectin-rich 
network towards the TCP particles. Once arrived, these osteogenic cells 
differentiate into osteoblast. The specific stimulus for osteoblast 
differentiation is not entirely clear and is likely multi-factorial. However, the 
local breakdown of TCP may contribute to the differentiation. Many authors 
have shown that a local rise in Ca2+ and PO4- ions stimulates osteoblastic 
differentiation (Sugimoto et al. 1993, Sugimoto et al. 1994, Honda et al. 
1995, Wu et al. 2003). The TCP material we used is highly porous (45-50%) 
and the size of the interconnecting micro-pores (5 -20 microns) clearly 
allows cell infiltration.  However the number of infiltrated cells decreased 
with increasing distance from the original bone surface, which likely acted 
as osteogenic cell source.  The highest bone production was seen in the areas 
where many positive cells had accumulated, that is in the SCT masses 
between particles and subsequently within particles. This suggests that the 
rate and ease of cell infiltration will subsequently determine the position of 
bone formation, i.e. first between particles, later in the particles. 
A second objective of this study was to examine the biodegradation 
of the TCP material. At six months of healing, we found that the borders of 
the previously round particles of TCP were now partly replaced by bone and 
by infiltrating SCT. Biodegradation of TCP can happen either by 
osteoclastic activity or by chemical dissolution by tissue fluids (Lu et al. 
1998).  In our study we did find TRAP positive cells in and around the 
particles. However, these cells were generally small and their number was 
rather limited. They clearly did not precede the osteogenic, Runx2 /Cbfa-1 
positive cells into the TCP particles: this distribution mimicked that of the 
osteogenic cells and was highest in the particles closest to the maxillary bone 
surface and lowest in the most apical particles. Most biodegradation of TCP 
was taking place around the cell-rich mass of soft connective tissue that 
locally seemed to remove TCP material while infiltrating the particles. 
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Fig. 4c High power magnification of negative control reacted with non-immune mouse IgG. 
Note the lack of positive (brown) staining. Counter-staining methyl green. (Original 
magnification x 400) 
Fig. 5 Graph showing the distribution of Runx2 /Cbfa-1 positive cells in three successive TCP 
particles moving away from the residual maxillary bone. Positive cells were assessed at 2 
different locations: 1, in the soft tissue infiltrating the TCP particle (SCT), this was either as 
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a mass of cells or as individual cells; and 2, in contact with the particle surface (Surface). 
The numbers of single cells infiltrating into the particle were few and contributed little to the 
total number of cells in the SCT (55± 19 for particle 1, 46 ± 32 for particle 2 and 15 ± 5 for 
particle 3). The amount of bone surrounding the particles is indicated in the horizontal bars.  
Values are means and s.d. of three patients.  
 
These cell masses were actively differentiating as suggested by their 
positive staining for Runx2 /Cbfa-1.  It is therefore possible that the 
metabolic activity of these cell masses produces acidic by-products which 
cause the chemical dissolution of the TCP. This, in combination with the still 
poorly developed vascularisation may cause a local drop in pH, which 
promotes the dissolution of the TCP. This does not exclude that osteoclastic 
activity contributes to the biodegradation process, but suggests that that 
contribution is rather limited. Dissolution of TCP observed in this study is in 
agreement with physico-chemical studies in vitro showing that these 
particles, suspended in Tris buffer at pH 7.2 and 37oC, indeed dissolve, at a 
rate of 0.57%/day (Curasan AG GmbH, unpublished data). 
 
 
Fig. 6 OPN stained section. Note the positive osteoblasts (white arrows) against bone tissue 
(B).  Some positive cells are also found in the soft connective tissue (SCT) surrounding the 
TCP particle (TCP), immediately next to the osteoblastic layer (black arrows). Occasionally 
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positive cells are found within the TCP (red arrows). The insert at upper right is a 
magnification of the box at lower left. (Original magnification x 200 and x 400 insert). 
In conclusion, this study confirms the hypothesis based on our 
earlier work (Zerbo et al. 2004) that the cells infiltrating around and within 
the tricalcium phosphate material are osteogenic.  The areas with little 
mineralised bone matrix seen in the apical part of biopsies at six months of 
healing (Zerbo et al. 2004) are therefore likely to continue to form bone and 
in time be fully replaced by bone tissue. This study confirms further that the 
mechanism of bone formation seen with this β- tricalcium phosphate 
(Cerasorb®) is related to the efficiency of cell in-growth and differentiation 
in this osteoconductive scaffold. The data suggests that the mechanism of 
degradation of the material is likely to be due to chemical dissolution and 
that the role played by osteoclasts is only minor.  
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Abstract  
  In previous histological studies we have investigated the 
performance of a porous β-tricalcium phosphate (TCP) (Cerasorb®) as a 
bone substitute for grafting in sinus floor augmentations.  The 6 months 
healing results showed immature woven bone formation and high quantities 
of osteoid around the TCP particles. In a further immunological study, we 
showed that the TCP particles were progressively being infiltrated with 
osteogenic cells, which substantiated the suggestion that bone formation in 
these areas was likely to continue. The purpose of the present study was to 
investigate the effect of a longer healing period on the quantity (% bone 
volume) and the quality (% lamellar bone) of the augmented bone.  
Biopsies were retrieved from three patients (2 biopsies per patient) 
who had undergone a sinus floor augmentation procedure with the TCP 
material and had healing times of 9 (n=2) and 14 (n=1) months.  
Histologically, all six biopsies showed thick trabecular bone in their 
coronal part. The TCP grafting material had almost completely been 
replaced by bone tissue. In all but one biopsy, a new cortex appeared to be 
forming in the most apical area of the biopsy.  
   The results show that the height of bone augmentation as well as 
the degree of bone maturity had increased remarkably with longer healing 
periods. There is evidence that a new cortex is forming at the most apical 
end of our biopsies. This study suggests that 9 months is a good time of 
healing before placement of dental implants in sinuses augmented with this 
TCP. 
 
Introduction 
Partially edentulous patients can be treated nowadays with dental implants in 
order to restore a functional occlusion. However, the posterior maxilla 
continues to pose a problem due to lack of bone height for implant 
placement. The sinus floor augmentation procedure, introduced first by 
Boyne & James (1980) and later modified by Tatum (1986), has become a 
standard treatment modality for these patients.  Despite the general 
agreement that autologous bone grafting is the golden standard (Block & 
Kent 1997), the problems of patient morbidity (Kalk et al. 1996) due to 
harvesting from the donor site continue to drive the search for bone 
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substitutes that are safe, effective and predictable. The quality and quantity 
of the bone into which the implant is placed is thought by many to have an 
effect on the survival rate of the dental implant (Jaffin & Berman 1991, Trisi 
& Rao 1999, Engquist et al. 1988).  
Tricalcium phosphates are known to behave as an osteoconductive 
material (Albrektsson & Johansson 2001), i.e., a material that permits bone 
growth into pores, channels or pipes. Osteoconduction is a time-related 
process, as the osteoprogenitor cells have to use the material as a scaffold for 
migration and bone deposition. In previous studies we have investigated the 
use of a porous β-tricalcium phosphate (TCP) (Cerasorb®) as a bone 
substitute for sinus floor augmentations (Zerbo et al. 2001; 2004a).  The 
results of 6 months healing showed a gain of about 3 mm of bone height. 
However the density of the new bone expressed as tissue volume percentage, 
was lower than the pre-existing residual bone and also lower than bone 
formed in sinuses augmented with autologous bone chips (Zerbo et al. 
2004a). Osteoid was present in high quantities, suggesting bone formation 
was still ongoing. In a subsequent immunological study (Zerbo et al. 2004b) 
we have shown that cells that had infiltrated around and within the TCP 
particles were potentially osteogenic, as shown by their expression of Cbfa-
1, a marker of bone cell differentiation. This data substantiated the 
suggestion that bone formation in and around the TCP particles was likely to 
continue in following months.  
The purpose of the present study was to investigate the effect of a 
longer healing period on the quantity (bone volume) and the quality (% 
lamellar bone) of the bone formed after grafting the sinus floor with TCP. 
We hypothesised that with longer times of healing the augmented bone 
density and maturity as well as the gain in bone height would increase. 
 
Materials and methods.  
Patient selection 
Three patients requiring a sinus floor augmentation procedure prior to 
dental implant placement were included in this study. All three patients were 
partially dentate and needed single sided (unilateral) augmentation and 
implants placement for anchorage of a posterior bridge. In all three cases, the 
residual ridge height was between 4 and 8 mm in the posterior maxilla.  
Chapter 6 
 92
Patients requested that no bone would be grafted for augmentation purposes. 
All  three selected patients were non-smokers.  
All patients signed a written consent form and were fully informed 
about the treatment.  The Ethical Committee of the Vrije Universiteit and the 
VU Medical Centre Hospital approved this research prior to commencement of 
treatment.  
 
Sinus floor elevation 
Full description of surgical procedures can be found in Zerbo et al 
(2004a). In brief, the sinuses were augmented according to Tatum (1986) 
method with Cerasorb® (diameter 1000-2000 µm) particles (Curasan AG, 
Kleinostheim, Germany). The augmented sites were then left to heal for 9 
months (patient no. 1 and 2) or 14 months (patient no.3, since this last 
patient had a stroke and could not be operated as previously planned at 9 
months due to anti-thrombotic treatment). There were no complications.      
Tetracycline bone labelling 
Bone labelling was performed after maxillary bone reconstruction 
by an oral dose of 250-mg tetracycline, 4 times a day during two days. The 
first dose was given 3 weeks before dental implant placement and the second 
dose, 1 week prior to implant placement and biopsy retrieval. 
Dental implant surgery and biopsy retrieval 
 At the time of implant placement, a hollow trephine burr with a 3.5 
mm (outer) diameter trephine burr (Straumann, Waldenburg, Switzerland) was 
used to prepare the site for implant placement and the inner core kept as a 
biopsy. ITI® full body screw (4.1 mm diameter) dental implants (Straumann, 
Waldenburg, Switzerland) were placed in all patients in the positions 
prepared with trephine burr.  
Histological procedures 
Tissue processing and staining were carried out as reported (Zerbo et al, 
2004a). In brief, the biopsies were fixed in 4% formalin in phosphate buffer, 
processed without decalcification and embedded in methylmethacrylate 
(MMA) at 4oC. Four groups of sections (5 µm thick) were cut with a 
distance of 150 µm between groups and stained with Goldner’s trichrome 
(Romeis 1989).   
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Fig.1. Overview of whole 
biopsy in which the newly 
forming “cortex” can be seen 
(red arrows). The soft tissue 
above this cortex (*) is part of 
the sinus mucosa. Note the 
trabeculae (black arrows found 
throughout the length of the 
biopsy. Some of the remaining 
TCP is indicated by the hash 
(#). Dotted line shows the 
approximate cutt of point 
dividing the residual Bone (RB) 
and the new bone (NB). 
* 
 # 
 # 
 # 
NB 
RB
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Histomorphometry  
Full description of the histomorphological procedures can be found 
in Zerbo et al. (2004a). In short, four evenly spaced-out sections (one from 
each group) were used for the measurements. A Leica DM RA microscope 
and a Leica DC 200 digital camera were used in combination with Leica 
QWin© (Leica Microsystems Image Solutions, Rijswijk, Netherlands) 
software. This was used to process and measure the digitised image. The 
measurements were carried out at 100-x magnification. The sections were 
marked with pen in order to delineate the margin between the existing 
(residual) alveolar bone (RB) and the new (augmented) bone (NB). Four 
fields of RB and NB were measured consecutively from each section, 
starting at the imaginary line dividing the RB and NB and moving away 
from each other. From each biopsy 4 sections were measured and the values 
were averaged.  
The total bone volume (BV) was calculated as the amount of 
mineralised bone tissue as a percentage of the total tissue volume (TV), thus 
(BV/ TV x 100 %) (Parfitt et al.1987). The osteoid volume was calculated as 
a percentage of the total tissue volume (OV/ TV x 100 %). In order to 
establish the maturity of the new bone, the amount of lamellar bone was 
quantified using a grid at 100 x magnification and polarised light. The 
percentage of lamellar or woven bone was calculated as a percentage of 
bone. 
The height of the augmented bone was measured in the biopsy 
sections as the distance between the highest point in the residual bone and 
the highest point of augmented bone, using an automatic stage table (see 
Zerbo et al 2004a). 
Lastly, fluorescent (tetracycline) labels were evaluated in unstained 
sections. The MAR (mineralization apposition rate) is the average distance 
between two fluorescent bone labels divided by the number of days between 
both courses of the antibiotic and expressed as µm/day.  
 
Results 
All three patients received two implants each, which allowed two 
biopsies per patient to be taken from the augmented sinus floor. All implants 
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appeared to have good primary stability, and there have been no implant 
failures at time of completion of this paper (10-12 months after placement). 
Six biopsies were retrieved in total. They were either placed in the second 
premolar and first molar positions (patients 1 and 2) or in the first and 
second molar position (patient 3). In the later patient, a loss of augmentation 
material was observed at the time of implant placement, in the distal position 
of the first molar. For this reason the implants were inserted in the mesial 
position of the first molar and in the second molar position. Biopsies 
presented some difficulty to be removed in one piece from the trephine burr.   
Histologically all biopsies showed bone formation into and around 
the TCP material. The margin between (old) residual bone (RB) and the new 
bone (NB) was more difficult to distinguish than in the previous study in 
which 6 months of healing had passed. However, distinction between the NB 
and RB could still be made, based on the presence of TCP remnants. In the 
areas adjacent to the RB, new bone had almost completely replaced the TCP 
material and the original boundaries of the particle were often no longer 
distinguishable. The regenerated bone increasingly resembled normal 
trabecular bone. It contained smooth-edged rods of interconnecting bone 
(often lamellar in type) which showed some preferential orientation, 
(especially in the 14 months biopsy, Fig 1 and 2), as opposed to the 
semicircular, rough-edged woven bone formed around the particles at six 
months of healing (Zerbo et al., 2004a). In five out of the six biopsies a new 
cortex appeared to be forming in the most apical areas of the biopsy. This 
compact layer of bone was found at the tip of all five biopsies and was 
thicker than the trabeculae found in the rest of the new bone (Fig.1). The 
new “cortex” contained new bone and large osteocytes, indicative of young 
osteocytes. In the one biopsy without this new cortex (from patient 2), bone 
formation was very abundant in the most coronal part of the biopsy, but had 
failed to form in the most apical part. The apical part of this biopsy was also 
the only one place where TCP particles were found without bone formation. 
In the coronal part of this biopsy, the new bone showed thick trabeculae and 
the TCP had almost completely been replaced by bone. 
 
 
 
 
Chapter 6 
 96
 
Fig. 2. Histological picture of bone (B) forming within and around TCP. Note the trabecular  
organisation of bone tissue with fatty bone marrow (FM) and blood vessels (BV) around it. 
White arrows show the osteoid present. Goldner’s trichrome stain. Orig. mag. x100. 
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Fig. 3. Detail of bone formation in relation to tricalcium phosphate (TCP).  Note the TCP 
remnants that are being replaced by new bone (B). Arrows indicate the layer of osteoblasts 
laying down osteoid (O) against the TCP remnants The new bone contains round osteocytes 
(arrowheads), indicative of young bone. Blood vessels (BV) can easily be distinguished in the 
area. Goldner’s trichrome staining. Original magnification x 200. 
 
Table 1 summarises the results for all measurements carried out in 
these three patients. In all three patients the bone volume in the augmented 
bone was similar to the residual maxillary bone of the same patient. Osteoid 
was found in the new (augmented) bone of all six biopsies. Layers of 
osteoblasts were found very often depositing osteoid against existing bone 
and replacing a receding soft connective tissue mass (Fig. 3). This 
connective tissue mass was well infiltrated by blood vessels supplying the 
area with nutrients (Fig. 3). In addition, fatty marrow tissue was often seen 
adjacent to the bone. 
The overall osteoid volume in the new bone was much greater than 
that found in the residual bone, which had hardly any osteoid formation. The 
osteoid volume in the new bone varied per biopsy (1.12 to 1.80 %, Table 1) 
but was in general not different to that found in our previous study with 6 
months healing (1.31 ± 1.01, Table 1).  
  The length of new bone formed was approximately 6 mm above the 
residual bone (see Table 1) providing adequate bone height for implant 
placement.  
Table 1 Histomorphometry results: 
Patient Residual 
bone 
New Bone 
N Sex Age 
(yr) 
Healing 
(mths) 
BV 
(%) 
OV 
(%) 
 
BV 
(%) 
OV 
(%) 
LB 
(%) 
MAR 
(µm/day) 
 
Length 
(mm) 
1 M 67 9 25 0.19 26 1.80 59 # 6.27 
2 F 48 9 21 0.08 20 1.12 38 1.4 5.88 
3 M 65 14 18 0.19 22 1.79 67 1.6 6.25 
Prev. 
study* 
52 6 31 
±  
16 
0.17 
± 
0.27 
17 
±  
5 
1.31
± 
1.01 
26  
± 
0.5 
1.3 
 ±  
0.4 
3.21 
±  
1.43 
 
BV%= bone volume as percentage of total tissue, OV %= osteoid volume as percentage of 
total tissue, LB%= lamellar volume as percentage of total bone tissue, MAR= mineral 
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apposition rate (µm/day). LB% of the residual bone was always approx.100%. The MAR was 
not measured for patient no 1 (#) since only single labels were found as result of incorrect 
intake of tetracycline. Previous study*:  the results of 6 months study (averages and standard 
deviations, n=9 patients see Zerbo et al. 2004 in press). 
 
Discussion 
  The histomorphometrical data of the present three cases strongly 
suggest that substitution of the TCP particles by bone tissue continued in the 
augmented sinus up till 14 months of healing. Other studies have shown that 
with increasing healing period, bioactive glass material is progressively 
replaced by bone (Tadjoedin et al. 2000, Cordioli et al. 2001). The present 
three cases were studied in order to investigate whether or not increasing the 
time of healing after grafting this TCP material (Cerasorb®) would also 
increase the quantity and quality of the bone tissue. The data suggests that 
indeed bone formation continued well past the 6 months period, as shown by 
the further increase of bone volume and the gain in bone height. The high 
osteoid volume found in these biopsies suggests that the period of bone 
regeneration around material is quite long and continues even after 9-14 
months of healing.  Bone maturation also increased with time as indicated by 
the ratio of lamellar versus woven bone. At six months of healing we had 
found a mean of 26 ±  0.5 % of lamellar bone in 9 patients (Table 1; Zerbo 
et al., 2004a). In the present study this figure varied between 38 and 67 %, 
which is indicative of the remodelling of the woven bone into lamellar bone. 
A high percentage of lamellar bone has been reported to be beneficial for the 
stability and survival of implants in this bone (Berglundh et al. 2003). 
It is reassuring to see the results of the total height of bone gained 
after 9-14 months of healing (5.8 mm- 6.2 mm). This is on average twice as 
high as in the 6 months group published earlier (Zerbo et al., 2004a). The 6 
months result of approximately 3 mm gain in bone height implied that bone 
augmentation would still be insufficient if the primary stability of the 
implants completely depended on the newly formed bone. Although the 
number of patients examined in the present study is very small, the data 
suggests that increasing the healing time to 9-14 months will provide enough 
bone height and bone volume to obtain implant stability regardless of the 
height of the residual bone.  
In the present samples we found several histological changes when 
compared with the 6 months cases. Firstly, the formation of a cortex at the 
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most apical end of the biopsy had not been seen previously. Cortex 
formation may have resulted from down- growth of osteogenic cells from the 
bony trap door in the coronal direction. As such, the removal of the lateral 
maxillary wall trap-door during sinus lifting is to be discouraged, as it 
potentially provides an additional source of osteogenic cells. The evidence of 
cortex formation in the apical part of the TCP graft is an indication that the 
apical growth may be ending and that predominantly remodelling and re-
establishment of the normal anatomic contour is taking place. The 
biomechanics of the bicortical maxillary bone has not been a point of focus 
in maxillofacial research. However, finite element analysis has shown that 
the maximum stress concentration in oral implants concentrates in the 
cortical bone and around the apex of the implant (Duyck et al. 1997). A re-
establishment of bi-cortification after sinus lifting is therefore likely to 
increase the stability of the implant. This also indicates that the mechanical 
function of the disturbed lateral wall of the maxilla must be returning to 
normal.  A second difference with the 6 months results is that in these more 
mature samples the bone tissue was characterised by a “normal” trabecular 
structure, with some remaining TCP within it. This differed from the 6 
months data where bone had formed in a haphazard manner, and 
predominantly in-between particles. Normal trabecula formation and 
bicortification, as well as increased bone volume and bone maturation, all 
point towards a greater stiffness of the graft after 9-14 months of healing. 
Fanuscu et al (2003) have recently shown that an increase in the stiffness of 
the graft in the augmented sinus will in turn distribute the stresses applied to 
the implant more evenly, thereby avoiding overloading of the native bone.  
In short, these cases have given some insight into the behaviour of 
this TCP material, Cerasorb®, when used in sinus floor augmentations with a 
prolonged healing time. The results suggest that the length of bone 
augmentation increases remarkably with longer healing periods and that the 
removal of the bony trap door during sinus lifting surgery should be 
discouraged. The bone volume continues to increase after an initial 6 months 
of healing. The formation of bone trabeculae is taking shape and the new 
bone becomes progressively lamellar. We find evidence that a new cortex is 
beginning to form at the apical end of our biopsies, suggesting that the bi-
cortical form of the maxilla is being re-established.  This study suggests that 
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9 months is an excellent time of healing for patients with moderate maxilla 
resorption (residual ridge greater than 4 mm and less than 8 mm) and treated 
with this TCP.In more severely resorbed maxillae however (less than 4 mm 
residual ridge), this healing period seems to be the lowest amount of time 
that should be used, due to additional augmentation required. 
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 Bone augmentation is currently common practice in orthopaedics, 
trauma surgery and plastic surgery. Also in oral and maxillofacial surgery 
bone augmentation has become increasingly popular in implant dentistry for 
pre-prosthetic surgery in order to optimise implant fixation and therefore the 
implant’s subsequent function. Placement of oral implants in the regenerated 
bone allows a biopsy of the augmented bone to be obtained that can be 
studied histologically. Detailed information on the process of bone formation 
and the behaviour of biomaterials can thus be obtained in patients. This 
thesis has concentrated on two methods of bone augmentation in the maxilla. 
Firstly, the monocortical bone block, an established technique for 
augmenting the anterior maxilla, usually in cases of anterior tooth 
replacement. The second and largest part of this thesis concentrated on bone 
augmentation using a synthetic bone substitute, Cerasorb®.  
 The use of autologous monocortical bone blocks is a well 
established technique for augmenting the anterior maxilla (Misch 1997, 
Jensen & Sindet-Petersen 1991, Widmark et al.1997; Hunt & Jovanovic 
1999; Montazem et al. 2000). Clinical experience has demonstrated that this 
is a successful technique for dental alveolar augmentations (Devlin et al. 
1994; Misch 1997), but the histological events were not well understood. 
The bone block acts as a scaffold, full of osteoinductive agents and cells that 
can promote its remodelling into new (live) bone (Merkx et al. 1999). 
However, it remained unknown if and to what extent the grafted bone block 
survives the grafting procedure. It was also not known what time it takes for 
the block to be completely replaced by new bone. In chapter 2, 19 patients 
that presented with defects in the anterior maxilla were grafted with bone 
blocks from the symphysis and left to heal for different lengths of time 
varying from 2.5 to 7 months. Biopsies were taken at the time of implant 
placement (i.e. after 2.5 to 7 months) and studied as histological sections. 
Quantification of the percentages of dead osteocytes at the different times of 
healing suggested that in the long run bone cells of the graft did not survive. 
The histological data of this retrospective study suggests that the non-vital 
bone graft is progressively replaced by new vital bone. Complete 
replacement is likely by the 7th month of healing.  
This success of monocortical bone blocks in dental-alveolar surgery 
is in contrast to the lack of success of cortical bone blocks in general 
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surgery. Our histological results suggest that the success of these grafts in 
dentistry can be attributed to their relative small size, which enables a 
relatively quick revascularisation and subsequent remodelling of the block. 
This in contrast to the much larger blocks used in general surgery, which 
must be used as vascularised grafts (Berggren et al. 1982, Plakseychuk et al. 
2003). Another factor adding to the success of these grafts in dentistry may 
be that they can be kept free of loading and movement during the healing 
period, which is usually not the case in general surgery.  
Bone regeneration in the edentulous posterior maxilla asks for a 
different approach. Here the defect is often much larger, but because of good 
confinement conditions a granulate bone substitute can be used. The 
presence of an appropriate scaffold, which allows the in-growth of vital 
components can be helpful and effective. These are a mixture of bone 
progenitors cells and a vascular supply to provide these bone cells with their 
required nutrients to allow them to differentiate and produce new bone 
matrix, and eventually supply them with required ions for the mineralisation 
process. Cerasorb® has been shown in animal studies to act as an appropriate 
scaffold (Merten et al. 2002, Wiltfang et al. 2002). Recent unpublished data 
from the manufacturer have shown that this material is >99% pure TCP with 
minor percentages of impurities of which 0.77% is hydroxy-apatite. The 
solubility of the TCP at 37 °C and pH 7.2 is 0.57% per day. The size of the 
pores in the particles averages at 30 ± 5 µm and varies between 0.1-50 µm. 
These pores are capable of absorbing tissue fluid and blood through capillary 
action, thus increasing the solubility of the particle. In chapter 3, a two case 
histological study is presented as a pilot study in order to gain information 
concerning this relatively new bone substitute, Cerasorb®. The material was 
used in a case of sinus floor augmentation and to fill a large cyst defect of 
the mandible. The study reports the ability of the material to be substituted 
by bone and laid the basis for a larger prospective study where the capability 
of this material would be compared with autologous trabecular bone, the 
“golden standard”.  
 In the prospective study, the bilateral sinus floor augmentation 
procedure was used as a model in which to have an intra-patient control 
(Tadjoedin et al. 2000; Szabó et al. 2001). In Chapter 4 we report on the 
findings of this prospective controlled human study which compared 
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augmentation by means of Cerasorb® with the autologous graft (bone chips 
from the symphysis) as control. Biopsies were retrieved after 6 months 
healing from 5 controlled (bilateral sinuses) and 4 uncontrolled (unilateral) 
patients. The histological findings confirm the osteoconductive properties of 
the TCP material, while the histomorphometrical data allowed quantitative 
comparison with the golden standard, the autologous bone. The average 
bone volume formed at the test (Cerasorb®) side was significantly lower to 
that of the control side. Osteoid formation however tended to be higher in 
the test side, indicating ongoing bone formation in the TCP material. The 
amount of lamellar bone at the test side was less than half the amount in the 
control side, indicating that remodelling had only recently started in the 
TCP-augmented side. Bone formation decreased with increasing distance 
from the residual maxilla. We found that Cerasorb® is an acceptable bone 
substitute at 6 months healing but only if the patient had enough residual 
bone to provide the implants with minimal primary stability. The biopsies 
also contained large areas where the bone substitute material was not 
replaced by bone but had been infiltrated by cells of unknown origin. 
 In the 5th chapter we investigated further the characteristics of the 
cells surrounding and infiltrating the TCP particles after six months. We 
used antibodies to the osteogenic marker Runx2/Cbfa1, an essential and 
early transcription factor for osteoblast differentiation, in order to study 
whether these cells were potentially osteogenic. The osteoblastic potential of 
the cells was further studied by immuno-staining for bone sialoprotein (BSP) 
and osteopontin (OPN) expression, molecular markers for bone cells. Most 
cells found within TCP particles stained positive for Runx2/Cbfa1 and some 
of them also stained positive for BSP and OPN. We concluded that contact 
with the TCP material promoted differentiation of progenitor cells into 
osteoblasts, and that more bone formation in and around the TCP particles in 
the ensuing months was likely. We also studied whether the degradation of 
the TCP material was due to chemical dissolution or due to resorption via 
osteoclasts, using the osteoclast marker tartrate-resistant acid phosphatase 
(TRAP). The histochemical results showed much degradation of the particles 
occurred in areas of high cell density but without large numbers of TRAP 
positive cells (presumably osteoclasts). Therefore, we concluded that it was 
unlikely that osteoclasts play a major role in the degradation of the TCP. 
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Chemical dissolution, possibly stimulated by local acidity due to high 
cellular activity, remains therefore the likely mechanism for TCP 
degradation.  
 If dissolution is the likely mechanism for the degradation of TCP, 
this suggests that increasing the outer surface areas of the particle might be 
beneficial to the degradation of the particles. Increasing the surface area may 
be achieved by decreasing the size of the particles and also by altering their 
shape, which is currently round. A sphere is the shape that has the least 
surface area per given volume; therefore any other shape would be better. 
We used particles of sizes ranging from 1000 to 2000 µm, but Cerasorb® is 
also delivered as smaller particles. The next smaller sizes vary from 500 to 
1000 µm, which may speed resorption and still allow enough time for bone 
formation. This balance between the time needed for bone formation and 
limiting time for particle degradation to occur would require further 
research. The finding that cell ingrowth and bone deposition were fastest in-
between particles (chapter 5) would further suggest that particle shapes that 
include large holes will stimulate ingrowth of cells and therefore better 
anchor the bone substitute in the new bone. Increasing the surface area of the 
particle may therefore not only result in faster particle dissolution but also 
faster bone regeneration and quicker stabilisation of the graft.  
 Lastly in chapter 6, a long-term case study of sinus lifting with 
TCP was carried out in order to determine whether with prolonged times of 
healing higher amounts of bone volume, bone height and maturity would be 
achieved. We found indeed higher bone volumes after 9 (2 patients) and 14 
(1 patient) months than after 6 months and also a much higher amount of 
lamellar bone. This indicates that bone continues to be deposited in this 
material, in line with the conclusion of chapter 5, and that remodelling of 
woven bone into lamellar bone is taking place. The height of bone 
augmentation had also doubled compared with six months. We concluded 
that 9 months is an acceptable healing time for placement of (non-loaded) 
implants, in sinuses augmented with 100% Cerasorb®. We can expect that 
the anchorage for implants in the sinus grafted with Cerasorb® is at 9 months 
healing no longer dependent of the primary stability from the residual bone.  
  The bone substitute particle alone is not enough to bring about 
bone growth. As mentioned earlier, a supply of osteoprogenitor cells is also 
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essential for the replacement of the material by bone (Albrektsson & 
Johansson 2001). This process is thought to start by migration of bone 
progenitor cells in and around the material, followed by their differentiation 
into osteoblasts which secrete osteoid. The source of progenitor cells in the 
case of sinus lifting is predominantly the original floor of the sinus, which 
then migrates ‘upwards’ (apically). This is however not the only source of 
cells since the sinus is naturally a multi-wall environment. The trap door 
which is pushed into the maxillary sinus is another bony surface that may 
spawn osteoprogenitor cells, which can then migrate outwards and 
‘downwards’ (coronally). This trap door varies in size and in thickness and 
in some cases is extremely thin (Van de Berg et al. 1998). The potential for 
cell outgrowth from such a thin sliver of bone may be questioned; however 
with hindsight we found some evidence in patients in the 6 months study 
(chapter 4) that there was extra bone growth in the most apical part to the 
biopsy. We cannot be certain that these cells derived from the trap door but it 
is certainly a likely explanation. This is further substantiated by the “new 
cortex” formation seen in chapter 6. Our observation therefore argues against 
removal of the bony trap door during sinus lifting surgery, which should 
therefore be discouraged.   
 The long term (9-14 months) observations show that the woven 
bone that is originally deposited in these TCP augmented sinuses is in time 
remodelled into lamellar bone, which is better at supporting forces during 
movement and muscle activity. In addition, we observed after long term 
healing the re-establishment of a bi-cortical anatomy in the augmented sinus, 
similar to the normal, functional maxilla. Remodeling is thought to be 
guided by mechanical function (Burr et al. 2002, Smit and Burger, 2000). 
The finding of large-scale remodelling suggests therefore that mechanical 
function has been re-established in this area; probably the gap between sinus 
floor and pushed-in trap door had been bridged by new bone. The formation 
of a cortex at the apical side supports this conclusion, but a realistic 
biomechanical model based on finite element analysis is needed to verify it.  
The search for an adequate bone substitute is mainly fuelled by the 
donor site morbidity in grafting autologous bone from symphysis 
(Raghoebar et al. 2001) or iliac crest (Kalk et al 1996). The bone substitute 
studied in this thesis has been shown to be an adequate in the sinus floor 
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augmentation. The limitations of the material were mainly due to the slow 
speed at which osteoconduction takes place as compared to the golden 
standard, autologous bone grafts. The time required was very much 
determined by the amount of augmentation required. This is due to the time 
that osteogenic cells take to grow into the augmentation space and would be 
inevitably shortened if autologous bone graft chips were mixed with the 
bone substitute. Nevertheless, in the 6 months healing data, despite 
variations between patients, an average of (approximately) 3 mm augmented 
bone had been gained while at 9 and 14 months this had doubled.  We 
conclude therefore that this synthetic TCP bone substitute can be a good 
alternative to bone grafts provided the clinician understands the limitations 
of the material.  
 Our results indicate that with this bone substitute (Cerasorb®) load 
bearing of the graft must be delayed for long periods. In oral implantology 
the augmentations required do not need to be immediately load bearing and 
the time of healing of a bone substitute or graft can be adjusted by delaying 
implant placement and/or implant loading, according to necessity. In 
orthopaedic surgery, many types of operations are carried out that require 
bone grafting, but with most of them load bearing is delayed only for a few 
days. This is a contra-indication for the use of a (Cerasorb®) graft. There are 
a few instances where this material may be able to play some useful role in 
orthopaedic surgery, when load bearing is limited by fixtures, e.g., intra-
lumbar fixtures and hand surgery. However, thorough study is further 
required before any definite conclusions can be made. 
In short, the present thesis gives the clinician insight into the 
histological changes taking place during bone augmentation procedures with 
autologous monocortical bone grafts or the bone substitute β-tricalcium 
phosphate (Cerasorb®). The results suggest some guidelines on the 
application of these grafts, but also show that the limitations of both 
materials still need adequate consideration. Our suggested guidelines should 
therefore always be used in conjunction with sound clinical judgement. 
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Conclusions 
Monocortical bone blocks: 
1. Augmentations in the anterior maxilla with block grafts of 
autologous bone result in vital bone of adequate quantity and quality 
for subsequent implant placement. 
2. The majority of osteocytes in monocortical bone blocks do not 
survive grafting. 
3.  Monocortical bone blocks remodel into vital bone via osteoclastic 
tunnelling followed by revascularisation and osteoclastic bone 
formation. This process of revitalisation takes at least 7 months. 
Beta-tricalcium phosphate: 
1. The β-TCP (Cerasorb®) is an osteoconductive bone substitute 
material, which allows replacement by vital bone tissue. 
2. The biological performance of the β-TCP has shown that the 
material is useful for sinus floor augmentation. 
3. The β-TCP material results in adequate bone for implant placement 
in 6 months provided that the primary implant stability is derived 
from pre-existing residual bone of the sinus floor. 
4. A 9 months healing time strongly increases bone quantity and 
quality, thereby allowing implant placement in those cases where 
primary stability of the implants is not provided by the residual bone 
of the sinus floor.  
5. The β-TCP material is not encapsulated by soft connective tissue, 
but replaced by bone. 
6. The β-TCP Cerasorb® is mostly degraded by chemical dissolution. 
 
Suggestions for future research 
- Controlled clinical studies are necessary with this β-TCP material 
(Cerasorb®) in combination with osteoinductive and osteogenic agents such 
as platelet enriched plasma (PRP), bone morphogenetic proteins (BMPs), or 
small amounts of autologous bone chips in order to determine the advantages 
of these additives. 
- Studies on the use of this material in other clinical situations including in 
orthopaedic surgery should be endeavoured. 
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- Studies are needed of the pattern of force distribution in the augmented 
sinus floor and its effect on bone growth and remodelling, using 
biomechanical finite element models. 
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 Botregeneratie met als doel het verkrijgen van een grotere botmassa,  
wordt tegenwoordig o.a. toegepast in de orthopedie, traumatologie en 
plastische chirurgie.Ook in de mond- en kaakchirurgie bestaat hiervoor veel 
belangstelling. Botregeneratie technieken worden steeds meer toegepast als 
pre-prothetische chirurgie voorafgaand aan het plaatsen van orale 
implantaten, om een optimale fixatie en daarmee een beter functioneren van 
het tandimplantaat te bewerkstelligen. Later, bij het plaatsen van het 
tandimplantaat in het geregenereerde bot kan zonder extra ongemak voor de 
patiënt een weefselbiopt worden afgenomen. Dit maakt het mogelijk om het 
geregenereerde botweefsel op histologisch niveau te bestuderen. Hierdoor 
kan van patiënten gedetailleerde informatie worden verkregen over het 
botvormingsproces en het gedrag van de biomaterialen in de patiënt. Dit 
heeft grote voordelen boven onderzoek aan proefdieren, die nooit een goed 
model voor de oudere edentate patiënt geven. 
  Dit proefschrift onderzoekt twee manieren van vergroting van 
botmassa in de bovenkaak. Ten eerste,  het gebruik van  mono-corticale 
botstukken, een bestaande techniek om botvolume te herstellen, meestal na 
voortijdig verlies van fronttanden. Ten tweede, het gebruik van een vrij 
recent op de markt gebrachte synthetische botvervanger, Cerasorb® om meer 
botmassa te creëren. De Cerasorb® studie beslaat het grootste deel van het 
proefschrift. In deze samenvatting wordt een korte bespreking van de 
resultaten gegeven, gevolgd door enige conclusies en  aanbevelingen. 
 Klinische studies hebben uitgewezen dat lichaamseigen bot van 
elders verkregen, met succes gebruikt kan worden  voor het opvullen van 
lokale kaakbot defecten (Devlin et al. 1994; Misch 1997). Hiervoor wordt 
vaak mono-corticaal bot uit eigen kingebied gebruikt. (Misch 1997; Jensen 
& Sindet-Petersen 1991; Widmark et al. 1997; Hunt & Jovanovic 1999; 
Montazem et al. 2000). Wat daarbij op  histologisch niveau plaats vindt, is 
onduidelijk. Het compacte corticale botstuk dient als een driedimensionale 
structuur, die voorziet in van botinducerende stoffen en cellen die de 
omzetting van het transplantaat in nieuw, levend botweefsel mogelijk maakt 
(Merkx et al. 1999).  Door het corticale karakter kan men het het botstuk met 
schroeven goed verankeren. Echter, bij het begin van dit onderzoek was 
onbekend in hoeverre het bottransplantaat de procedure op den duur zou 
overleven. Ook  was onbekend hoe lang het duurt voor het gehele 
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bottransplantaat is vervangen door nieuw bot. In hoofdstuk 2 werd bij 19 
patiënten een botdefect  in het front van de bovenkaak opgevuld met een 
mono-corticaal botstuk uit de kin. Tweeëneenhalf tot  7 maanden later werd 
een biopt genomen op de plaats waar een tandimplantaat werd geplaatst. De 
botbiopten werden verwerkt tot histologische coupes en de botvorming is 
microscopisch bestudeerd. Het blijkt dat al na 2,5 maand zeer veel osteocyt 
lacunen in het getransplanteerde bot geen cel meer bevatten, wat erop wijst 
dat de osteocyt is dood gegaan. Tevens tonen de histologische gegevens uit 
deze studie aan dat dit niet-vitale bot geleidelijk wordt vervangen door 
nieuw vitaal botweefsel. Na 7 maanden lijkt het oorspronkelijke 
transplantaat geheel vervangen te zijn door nieuw, vitaal bot. 
 Het succes van mono-corticale botstukken als transplantaat bij 
kaakbotoperaties is opmerkelijk, gezien het geringe succes van compacte 
bottransplantaten in de algemene chirurgie. Onze histologische bevindingen 
duiden er op dat het positieve resultaat van monocorticale kinbot 
transplantaten is toe te schrijven aan hun relatief klein formaat, waardoor een 
snelle revascularisatie mogelijk wordt, gevolgd door ombouw van het 
botstuk. Dit in tegenstelling tot de veel grotere botstukken in de algemene 
chirurgie, die dan ook gevasculariseerd (gesteeld) moeten worden geplaatst 
(Berggren et al. 1982, Plakseychuk et al. 2003). Een bijkomende factor voor 
het succes van kinbot transplantaten in de tandheelkunde is dat er niet of 
nauwelijks belasting of verschuiving optreedt, gedurende het 
genezingsproces. Dit is meestal niet te  verwezenlijken bij de algemene 
chirurgie. 
 Botregeneratie meer achterin in de tandeloze bovenkaak vraagt een 
andere benadering. Daar ontbreekt vaak botmassa vanwege de grote 
gepneumatiseerde sinusholte. Daarnaast is door het slinken van de 
bovenkaak, na verlies van de kiezen, vrijwel geen bothoogte meer aanwezig 
onder de bodem van de sinus maxillaris. Door de sinusbodem te verhogen, 
ontstaat een goed begrensde ruimte. Hierdoor is het gebruik van een 
botvervanger in korrelvorm mogelijk. Via de korrels is ingroei van 
bloedvaten en botweefsel mogelijk, een proces dat osteoconductie wordt 
genoemd. Ingroei van bloedvaten zorgt er voor dat de voorlopers van de 
botcellen, die met bloedvatcellen mee migreren,  van voedingsstoffen 
worden voorzien. Hierdoor kunnen ze zich differentiëren tot functionele 
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botcellen (osteoblasten) die een nieuwe collagene botmatrix maken en deze 
vervolgens  mineraliseren. Uit experimentele dierstudies was al gebleken dat 
Cerasorb®  kon fungeren als een geschikte structuur voor vorming van nieuw 
bot (Merten et al. 2002, Wiltfang et al. 2002). Cerasorb® is een synthetisch 
calciumfosfaat zout en bestaat voor meer dan 99% uit zuiver ß-tricalcium 
fosfaat (ß-TCP) met slechts zeer geringe percentages onzuiverheden, 
hoofdzakelijk  hydroxylapatiet (0,77%) (ongepubliceerde gevens van de 
fabrikant). De oplosbaarheid van dit TCP in een celvrije buffer bij 37 ºC en 
pH 7,2 is 0,57% per dag. De korrels bevatten veel poriën met een 
gemiddelde porie grootte van  30 µm variërend tussen de 0.1 en 50 µm. De 
poriën zijn door hun capillaire werking in staat om weefselvloeistof en bloed 
te absorberen en verhogen  hierdoor de oplosbaarheid van de korrels. In 
hoofdstuk 3, wordt een retrospectief histologische onderzoek van twee 
klinische casussen beschreven als een voorstudie om informatie te verkrijgen 
over dit relatief nieuwe botvervangingsmateriaal.  Bij één patiënt werd het 
TCP materiaal gebruikt voor een verhoging van de sinusbodem en bij een 
andere patiënt voor het vullen van een botdefect in de onderkaak dat 
ontstaan was door de vorming van een grote cyste. Het onderzoek bevestigde 
dat het botsubstituut kan worden omgezet in vitaal bot en dit legde de basis 
voor een grotere prospectieve studie waarin de bruikbaarheid van dit 
materiaal wordt vergeleken met die van gefragmenteerd autoloog trabeculair 
bot. Dit laatste wordt algemeen beschouwd als de “gouden standaard” van 
alle tot nog toe bekende botmaterialen. 
 In de prospectieve studie werd de dubbelzijdige (‘split mouth’) 
sinusbodem verhoging procedure gebruikt als testmodel om het gedrag van 
TCP korrels als botsubstituut na te gaan. In dit (humane) model fungeert de 
ene helft van de bovenkaak als experimentele kant en de andere helft als 
controle kant (Tadjoedin et al. 2000; Szabó et al. 2001). In hoofdstuk 4 
beschrijven we de resultaten van deze prospectieve, gecontroleerde studie 
waarin de toename in botvolume bij gebruik van Cerasorb®  (testkant) wordt 
vergeleken met die van gefragmenteerd autoloog botweefsel uit de kin 
(controle kant). Biopten werden verkregen 6 maanden na transplantatie, 5 
biopten van  'gecontroleerde' (dubbelzijdig behandelde) en 4 van 
'ongecontroleerde' (enkelzijdig behandelde) patiënten. De histologische 
bevindingen bevestigden de osteoconductieve eigenschappen van het TCP 
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materiaal. Meting van de hoeveelheid gevormd  bot en van het onverkalkte 
voorstadium van bot (osteoid), maakte een vergelijking mogelijk tussen het 
botvormend vermogen van TCP en dat van autoloog bot. Het gemiddelde 
botvolume aan de experimentele (Cerasorb®) zijde was significant lager dan 
in de controle kant. Echter, de hoeveelheid osteoid was hoger aan de 
experimentele kant dan in de controle kant. Dit wijst er op dat in de 
experimentele kant na 6 maanden nog steeds botvorming plaats vindt, terwijl 
in de controle kant de botvorming tot stilstand is gekomen. 
De hoeveelheid volwassen, lamellair bot aan de experimentele kant bleek 
minder dan de helft van de hoeveelheid aan de controle kant. Dit wijst erop 
dat de ombouw van het eerstgevormde jonge vezelbot in de experimenteel 
kant (TCP)  pas kort voor het nemen van het biopt was begonnen, en bij de 
controle kant al veel eerder. De botvorming nam af naarmate de afstand tot 
het oorspronkelijke kaakbot groter werd. De biopten bevatten verder grote 
delen waar de TCP korrels niet waren vervangen door bot, maar wel 
geïnfiltreerd en omgeven waren door bindweefselcellen van onduidelijke 
herkomst. Wij concludeerden dat Cerasorb®  een acceptabel 
botvervangingsmateriaal is, waarin 6 maanden na aanbrengen een 
tandimplantaat geplaatst kan worden maar alleen als de patiënt genoeg 
resterend kaakbot heeft om de implantaten primaire stabiliteit te geven.  
In hoofdstuk 5 onderzochten we verder de eigenschappen van de 
bindweefselcellen die de TCP korrels na 6 maanden hadden omringd en 
geïnfiltreerd. We gebruikten antilichamen tegen de moleculaire marker 
Runx2/Cbfa1, een essentiële en vroege transcriptiefactor voor osteoblast 
differentiatie. Hiermee bekeken we of de cellen in en om de TCP korrels 
zich tot botcellen zouden kunnen ontwikkelen, of dat ze dit vermogen niet 
hadden maar de korrels zouden inkapselen met bindweefsel. De 
aanwezigheid van botvoorlopercellen  die al verder gedifferentiëerd zijn in 
de richting van een functionele osteoblast werd verder onderzocht door 
immunokleuringen voor botsiaalzuur-bevattend eiwit  (bone sialoprotein, 
BSP) en osteopontine (OPN). Beide eiwitten zijn moleculaire markers voor 
botcellen (osteoblasten en osteocyten). De meeste cellen in de poriën en 
rondom de TCP korrels kleurden positief voor Runx2/Cbfa1 en sommigen 
van hen kleurden ook positief voor BSP en OPN. We concludeerden hieruit 
dat de meeste bindweefselcellen rondom de korrels potentiële voorlopers van 
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botcellen waren, dat contact met het TCP materiaal de differentiatie van deze 
voorlopercellen tot osteoblasten bevordert, en dat daarom verdere 
botvorming in en rond de TCP korrels in de navolgende maanden 
aannemelijk zou zijn. Met behulp van tartraat resistente zure fosfatase 
(TRAP), een  osteoclast marker, onderzochten we ook of het verdwijnen van 
het TCP materiaal het gevolg was van resorptie door botafbrekende cellen 
(osteoclasten) of door chemisch oplossen in weefselvloeistof. Uit de 
histologische resultaten bleek dat de korrels vooral oplossen op plaatsen met 
een hoge celdichtheid maar zonder aanwezigheid van veel TRAP-positieve 
cellen (osteoclasten).  Hieruit concluderen wij dat het onwaarschijnlijk is dat 
osteoclasten een belangrijke rol spelen bij het verdwijnen van TCP. 
Chemisch oplossen, mogelijk gestimuleerd door lokale weefselverzuring als 
gevolg van hoge metabolische activiteit van cellen, lijkt daarom de meest 
aannemelijke reden voor het verdwijnen van TCP. 
 Indien oplossen van de korrels in weefselvloeistof het meest 
waarschijnlijk is voor verdwijnen van TCP,  dan impliceert dit dat vergroting 
van het buitenoppervlak van de TCP korrels het oplossen van de korrels kan 
versnellen. Een (relatieve) toename van het oppervlak kan worden verkregen 
door kleinere korrels te gebruiken dan wel door hun vorm te veranderen, die 
nu rond is. Een bol is de vorm met het kleinste oppervlak bij een gegeven 
volume, elke andere vorm zal dus een (relatieve) vergroting van het 
oppervlak tot gevolg hebben. We gebruikten in deze studie korrels die 
variëerden in doorsnee van 1000 tot 2000 µm. Cerasorb® is echter ook 
verkrijgbaar in kleiner formaat, varïerend in grootte van 500 tot 1000 µm. 
Dit kleiner formaat verhoogt de oplosbaarheid van de korrels maar verkort 
daarmee de tijd voor ingroei van botweefsel. Voor het bepalen van het juiste 
evenwicht tussen de tijd die nodig is voor botingroei en de tijd van oplossen  
van de korrrel is nog verder onderzoek nodig.  
De waarneming dat de ingroei van cellen en de aanmaak van bot het 
snelst waren in de ruimte tussen de korrels (hoofdstuk 5) wijst er op dat de 
aanwezigheid van grote holtes de ingroei van cellen stimuleert. De korrels 
worden daardoor ook sneller verankerd in het nieuwe bot. Vergroting van 
het oppervlak van de korrels kan daardoor niet alleen hun verdwijnen 
versnellen maar ook een snellere botregeneratie en stabilisatie van het 
transplantaat tot gevolg hebben. 
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 Als laatste werd in hoofdstuk 6  een histologische evaluatie verricht 
van biopten die pas 9 maanden (twee patiënten) dan wel 14 maanden (1 
patiënt) na sinusbodem verhoging met TCP zijn afgenomen. Bekeken werd 
of de bothoogte, het botvolume en de vorming van volwassen lamellair bot 
verder zouden toenemen met de tijd. We vonden inderdaad meer botvolume 
na 9 en 14 maanden dan na 6 maanden en ook was het percentage lamellair 
bot verder toegenomen. Dit wees er op dat ook in de periode na 6 maanden 
de botvorming rond de TCP korrels in de sinus was doorgegaan. Dit was, in 
overeenstemming met de conclusie uit hoofdstuk 5. Ook had verdere 
ombouw van vezelbot naar lamellair bot plaatsgevonden.  De hoogte van het 
kaakbot was verdubbeld  in vergelijking tot de zes-maands groep; van 3 mm 
tot bijna 6 mm. We concludeerden dat 9 maanden na transplantatie van 
Cerasorb® in de sinus maxillaris, de sinusbodem voldoende is verhoogd om 
(onbelaste) implantaten te kunnen plaatsen. Op grond van deze resulaten 
verwachten we dat na 9 maanden de primaire stabiliteit van tandimplantaten 
in de met Cerasorb® verhoogde sinusbodem niet langer afhankelijk is van het 
oorspronkelijk aanwezige bot. 
 Het botvervangingsmateriaal alléén is niet voldoende om botgroei te 
bewerkstelligen. Zoals eerder opgemerkt is, is een goede aanvoer van 
botvoorlopercellen essentiëel voor de vervanging van Cerasorb® door 
botweefsel (Albrektsson & Johansson 2001). Vermoedelijk begint dit proces 
met migratie van botvoorlopercellen vanaf de bestaande botrand  tussen en 
in de TCP korrels ‘naar boven’ (apicaal), waarna differentiatie van de cellen 
tot osteoblasten plaats vindt die vervolgens osteoid afzetten. Omdat de sinus 
maxillaris meerwandig is, kunnen de botvoorlopercellen ook afkomstig zijn 
van andere botoppervlakken dan de oorspronkelijke sinusbodem. Met name 
het botluikje dat naar binnen wordt geklapt tijdens het aanbrengen van het 
regeneratiemateriaal, kan als bron van voorlopercellen dienen die ‘zijwaarts’ 
en ‘naar beneden’ (incisaal) migreren. Dit luikje variëert per patiënt in 
omvang en dikte en is soms erg dun (Van de Berg et al. 1998). De 
mogelijkheid van celuitgroei uit zo'n dun plakje bot lijkt aanvechtbaar. 
Achteraf vonden we aanwijzingen dat ook in de patiënten van de 6-maands 
studie (hoofdstuk 4)  extra botgroei had plaats gevonden aan de ‘bovenkant’ 
van het biopt. Hoewel het niet zeker is dat de cellen van dit “apicale” bot 
afkomstig zijn van het botluikje is het wel een mogelijke verklaring voor 
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onze waarnemingen. Dit wordt verder ondersteund door de vorming van een 
cortex-achtige structuur aan de bovenkant die bij de 9 en 14 maands biopten 
werd waargenomen. Onze bevindingen zijn een reden om het botluikje 
tijdens de sinusbodem verhoging procedure niet te verwijderen, zoals door 
sommige auterurs wordt aanbevolen. 
De lange termijn (9-14 maands) waarnemingen laten zien dat eerst 
vezelbot wordt aangelegd in de deels met TCP korrels gevulde sinus. 
Mettertijd wordt dit vezelbot omgebouwd tot lamellair bot dat beter is 
aangepast aan de mechanische belasting van de kaak tijdens kauwen en 
andere spieractiviteit. Tevens zagen we op lange termijn de vorming van een 
bi-corticale anatomie van het bot dat in de voormalige sinus gevormd werd, 
vergelijkbaar met het bot in de normale, functionele bovenkaak. 
Aangenomen wordt dat lokale botombouw gestuurd wordt door de 
mechanische functie van botweefsel (Burr et al. 2002; Smit and Burger 
2000). Het feit dat in de opgehoogde sinus bodem remodelering van het 
nieuw gevormde bot op grote schaal plaats vindt, suggereert daarom dat in 
dit gebied de mechanische functie is hersteld,  waarschijnlijk doordat de 
ruimte tussen de voormalige sinusbodem en het naar binnen geklapte luikje 
is overbrugd door nieuw bot. Om hier zekerheid over te verkrijgen, is een 
realistisch biomechanisch model nodig gebaseerd op eindige elementen 
analyse. Met zo’n model zou onze verklaring kunnen worden getoetst.  
Het ongemak van de patiënt ten gevolge van het afnemen van 
donorbot uit de kin (Rhaghoebar et al. 2001) of het bekken (Kalk et al. 1996) 
nodig voor autotransplantatie, stimuleert het zoeken naar synthetische 
botvervangers. Dit proefschrift laat zien dat het hier bestudeerde TCP 
materiaal een goede botvervanger is voor de sinusbodemverhoging. 
Rekening houdend met enige variatie tussen de patiënten, werd met dit 
materiaal na 6 maanden een gemiddelde van omstreeks  3 mm nieuw bot 
verkregen terwijl na 9 en 14 maanden deze hoogte was verdubbeld. Wij 
trekken daaruit de conclusie dat een synthetische botvervanger als TCP een 
goed alternatief kan zijn voor autologe bottransplantaten mits de klinicus de 
beperkingen van het materiaal kent. Met name de lage snelheid waarmee 
botregeneratie plaats vindt, vergeleken met autoloog transplantatiebot is een 
nadeel van dit materiaal. De regeneratietijd wordt voornamelijk bepaald door 
de hoeveelheid te vormen bot en de snelheid waarmee de pre-osteoblasten de 
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met korrels gevulde ruimte ingroeien. Deze tijd kan mogelijk bekort worden 
door de TCP korrels te mengen met een kleine hoeveelheid autologe bot 
deeltjes, zoals die kunnen worden opgevangen middels een “bone trap 
device”. Met dit apparaatje kunnen de botsplintertjes die tijdens het uitzagen 
van het luikje vrijkomen  worden opgevangen. Het verdient aanbeveling om 
te onderzoeken of toevoegen van “bone-trap bone” de bruikbaarheid van 
Cerasorb® TCP korrels kan vergroten. 
 Onze studies suggereren ook dat bij de hier bestudeerde 
botvervanger belasting van het transplantaat voor langere tijd moet worden 
uitgesteld. In de orale implantologie is dit geen groot bezwaar aangezien de 
belasting kan worden gereguleerd door het plaatsen en/of functioneel 
gebruik van het tandimplantaat zonodig uit te stellen. In de orthopedische 
chirurgie is het vaak veel moeilijker om met zekerheid te voorkomen dat een 
bottransplantaat voortijdig wordt belast.  Dit is een contra-indicatie voor het 
gebruik van  uitsluitend Cerasorb® korrels als transplantatiemateriaal. Indien 
voortijdige belasting kan worden beperkt door interne of externe fixaties, 
bijvoorbeeld  van wervellichamen of bij botbreuken in de hand, zou dit 
materiaal ook nuttig kunnen zijn in de orthopedische chirurgie. Wel is meer 
onderzoek nodig voordat, voor deze specifike toepassingen, een definitieve 
conclusies getrokken kunnen worden. 
Samengevat, dit proefschrift geeft de klinicus inzicht in de 
histologische veranderingen die plaats vinden tijdens botregeneratie met 
behulp van een autoloog mono-corticaal bot transplantaat of een synthetische 
botvervanger, bestaande uit ß-tricalcium fosfaat (Cerasorb®). De resultaten 
geven een globale leidraad voor de toepassing van deze biomaterialen, maar 
benadrukken ook dat rekening gehouden moet worden met de beperkingen 
van beide materialen.  De aanbevelingen die wij doen moeten daarom altijd 
beoordeeld worden in samenhang met een gezond klinisch oordeel. 
 
Conclusies en Aanbevelingen: 
Met betrekking tot monocorticale botstukken: 
1. Autologe transplantatie van kinbot naar kaakdefecten in het 
bovenkaakfront leidt tot vorming van vitaal bot van 
voldoende omvang en kwaliteit om tandimplantaten te 
kunnen plaatsen. 
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2. De meerderheid van de osteocyten in een mono-corticaal 
botstuk overleeft de transplantatie niet. 
3. Het corticale botstuk wordt omgebouwd tot nieuw vitaal bot 
door activiteit van osteoclasten, revascularisatie en nieuwe 
botvorming door osteoblasten. Dit proces van ombouw 
duurt tenminste 7 maanden. 
Met betrekking tot β-tricalcium fosfaat korrels (Cerasorb®): 
1. Het β -TCP (Cerasorb®) is een osteoconductieve 
botvervanger die omgezet wordt in vitaal bot. 
2. Het biologisch gedrag van β -TCP maakt dit materiaal 
bruikbaar voor sinus bodem verhoging. 
3. Gebruik van dit materiaal leidt tot bot van voldoende 
dichtheid  en kwaliteit om na 6 maanden tandimplantaten te 
kunnen plaatsen, mits de primaire stabiliteit van het 
implantaat wordt gewaarborgd door het resterende 
oorspronkelijke bot van de sinus bodem. 
4. Minimaal 9 maanden na het aanbrengen van Cerasorb® in de 
sinus geeft de dichtheid en kwaliteit van het gevormde bot 
voldoende primaire stabiliteit om tandimplantaten te 
plaatsen zonder rekening te houden met het resterende bot 
van de sinus bodem. 
5. Het Cerasorb® materiaal wordt niet ingekapseld door zacht 
bindweefsel, maar vervangen door botweefsel.  
6. Het Cerasorb materiaal wordt voornamelijk afgebroken door 
chemisch oplossen in weefselvloeistof. 
Suggesties voor toekomstig onderzoek 
- Gekwantificeerde en goed gecontroleerde klinische studies zijn 
nodig om na te gaan of toevoeging van kleine hoeveelheden vitale 
(autologe) botfragmenten of botinducerende groeifactoren (zoals 
platelet enriched plasma, PRP,  bone morphogenetic proteins, 
BMPs) de botvorming in relatie tot Cerasorb korrels kunnen 
stimuleren. 
-  Studies zijn gerechtvaardigd naar het gebruik van dit materiaal in 
andere klinische situaties waaronder de orthopedische chirurgie. 
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     -   Studies zijn nodig naar het krachtenverdelingspatroon in de 
verhoogde sinusbodem bij belasting en het effect daarvan op de 
botgroei en botombouw. Gebruik van eindige elementen analyse is 
daarbij zeer wenselijk 
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